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1I General introduction
1 The endocrine system and endocrine disruption
The regulation of various processes and the communication in the body by means of the 
interaction of glands, hormones and receptors is referred to as the endocrine – or hormone –
system. The synthesis and secretion of hormones is carried out by distinct glands and cells
that are located at different sites of the body [1], while several hormones can be synthesized 
by the same gland [2]. Hormone-sensitive parts of the human body are demonstrated in the 
illustration below (Figure 1). 
Hormones are essential for the communication and other functions in the body and are 
important signaling molecules that are transported through the bloodstream until they reach 
their target tissues or cells [1,2]. In these tissues and cells, the hormones are bound by 
respective receptors causing distinct effects or responses such as the production of specific 
substances or specific changes in the metabolism [1,2]. At this, the interaction of hormones 
and receptors is dependent on both the type of the hormone and the receptor. Derived from 
different precursors (e.g. cholesterol is the precursor of steroids) the four classes of 
hormones are i) steroids, ii) amines leading to thyroid hormones and catecholamines, 
Figure 1 Outline of the endocrine system showing the hormone-sensitive sites of the human body (model 
according to [3])
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2iii) peptides/proteins, and iv) eicosanoids [1]. The major receptor classes are receptors on 
the cell surface (membrane receptors), in the cell cytoplasm and in the cell nuclei (both 
intracellular receptors), binding different types of hormones [1].
Distinct biological and physiological processes in the human body are controlled by different 
hormones. For example, estrogen and testosterone are involved in the development and 
function of the reproductive system, insulin in the control of the blood sugar, further 
hormones like thyroid hormones are important for other regulations such as the development 
of the brain and the nervous system [1]. Therefore, hormones and the entire endocrine 
system play an essential role for human health while any disruption can have serious 
consequences like disease or death [2]. At this, a disruption can have ‘natural reasons’
(medical condition like genetic defects) or can be caused by exogenous influences (ingested,
inhaled or absorbed substances). Possible consequences might be problems during growth, 
disturbances of metabolic processes or the brain function due to impaired thyroid hormones 
but also infertility or other reproductive problems when the normal balance of sex hormones 
is disrupted [2]. Even death can be the consequence of a disrupted hormone system, like in 
patients with a type I diabetes if their lack of insulin is not treated [2].
Any interference of the endocrine system or any influence on it by diverse chemicals or 
substances called endocrine disrupting chemicals (EDC) is referred to as endocrine 
disruption. The World Health Organization (WHO) stated the following definition of a 
(potential) endocrine disruptor in the course of the International Programme on Chemical 
Safety (IPCS 2002): “An endocrine disruptor is an exogenous substance or mixture that 
alters function(s) of the endocrine system and consequently causes adverse health effects in 
an intact organism, or its progeny, or (sub)populations. A potential endocrine disruptor is an 
exogenous substance or mixture that possesses properties that might be expected to lead to 
endocrine disruption in an intact organism, or its progeny, or (sub)populations.” [4–6].
The disruption of the endocrine system by EDC is effected via various mechanisms, mainly 
via steroid hormone receptors that are part of the nuclear receptor superfamily and that 
regulate transcriptional activation [7]. Besides, also other mechanisms are involved, for 
example, mechanisms via nonnuclear steroid hormone receptors like membrane receptors, 
via non-steroid receptors and others [3].
Intracellular receptors are activated by binding ligands resulting in conformation changes, 
and subsequently the activated receptors bind to responsive elements of genes to initiate 
their transcription [8]. Consequently, messenger ribonucleic acid (mRNA) is produced by 
means of the enzyme RNA polymerase, which conveys the information from the cell nucleus 
into the cytoplasm where it is translated at ribosomes resulting in the production of the target 
3protein [8]. At any time, these steps can be interfered, while an EDC can not only act as a 
hormone mimic, but can also be an antagonist or inhibitor, influencing the normal 
physiological processes of the body. An EDC, thus, can have impacts on metabolic 
processes such as the synthesis, excretion and metabolism of hormones, can alter hormone 
receptor levels or can cause disorders in the transport of hormones but also can interfere 
associated translations and transcriptions [1,5,9,10]. Furthermore, an endocrine disruption 
can cause alterations of signaling pathways, development and other biological processes [1].
A number of different scientific institutions work in this field of research and a large number of 
literature is concerned with this often reviewed topic (see reviews [3,9,11]). Amongst other 
things, EDC are blamed for influencing various stages of the development of organisms, and 
for having negative effects on the fecundity as well as for being responsible for birth defects 
and metabolic disorders in mammals, fish and birds, as well as in reptiles and mollusks in 
Europe, North America and other localities [12,13]. For many of known or suspected EDC 
that occur in our environment the actual effects on humans and wildlife are, however, still 
uncertain, while for some EDC the connection between the specific substance and its 
disrupting properties was confirmed. 
Amongst the great spectrum of compounds with biological activity at the endocrine system
inter alia natural and synthetic hormones, organotins [14], organochlorines [15], alkylphenolic 
compounds [16,17], and cosmetic UV filters [18,19] are involved, but also other chemicals 
and substance groups have been proved to be active at the endocrine system or are 
supposed to be EDC. A great number of these substances are persistent, lipophilic and have
a low vapor pressure, why they – supported by the global transport – are to be found all over 
the world [20]. Others, however, have a shorter lifespan and can be detected in higher 
amounts near their sources [6]. Additionally, EDC also may be formed by in vivo activation or 
(bio)degradation resulting in endocrine active (breakdown) products [5,6,20]. Because of the 
various characteristics and sources, EDC occur in soil and air as well as in water 
(groundwater, surface water) [5,6]. Furthermore, EDC are substances that are used very 
commonly, e.g. during the production of plastics, commodities or in formulations of plant 
protection agents or cleaning products, and even can accumulate in the food chain, so as to
an exposure with EDC via a number of routes is possible. This comprises drinking, breathing, 
diet, but also exposure through direct contact, e.g. at work or via consumer products [3].
Moreover, for infants and fetuses, a possible exposure through their mothers is of great 
importance and concern [2].
4In the 1990s, studies presented an observed reduction of the sperm count and seminal 
volume in men and simultaneously an increasing number of abnormalities in the 
genitourinary system like cryptorchidism, testicular cancer and hypospadias over the period 
of the preceding 50 years [21,22]. This was assumed to be related to environmental 
influences, inter alia, due to a simultaneously occurring increase of EDC in the environment,
since genetically changes are unlikely in this rather short period of time [21]. Furthermore, it 
was also assumed that an increasing exposure with estrogen active compounds (EAC) lead 
to disorders of the male reproductive tract [23], especially when exposure took place in utero
since, for example, testicular cancer is presumed to be initialized early in life [24]. Henderson 
et al. suspected exogenous hormone use during pregnancy, particularly during the time of 
differentiation of the testes of male fetuses, as a major risk factor for testicular cancer in 
young men [25]. Moreover, a study in Denmark concluded that elevated estrogen levels 
during first pregnancies pose a risk for testicular cancer in male offspring (first born sons) 
[24].
Such studies and observations demonstrate that not only exposure to endogenous or
exogenous natural hormones but also exposure to other endocrine active substances 
occurring in our environment can lead to a disruption or to alterations in humans and wildlife. 
This is also true for endo- and exogenous natural estrogens and EAC, which is to be dealt 
with in the ensuing chapter.
52 Estrogens and estrogen active compounds (EAC)
2.1 Assays for the detection of estrogens and estrogen active compounds
Several in vivo and in vitro assays were developed for the detection and determination of 
estrogen active compounds (EAC). According to Leusch, the application of bioassays is of
advantage compared to other chemical (chromatographic) methods since the specific 
chemical nature of the substances does not have to be known and lower detection limits are 
achievable [26]. By using most of the available bioassays, admittedly the estrogenic activity 
of a sample or of specific substances can be detected, but the identity of the individual
estrogen active components of a sample cannot be determined. In order to detect and 
determine single compounds, therefore, usually an additional analysis, for example with high-
performance liquid chromatography or gas chromatography, is required. In case of unknown 
substances, an identification employing mass spectrometry (MS) can be performed.
The development of the planar yeast estrogen screen (pYES), however, provided the option 
to separate the single EAC of a sample by high-performance thin-layer chromatography 
(HPTLC), and subsequently detect and determine them in the same assay. At this, the 
compounds of a sample are chromatographically separated on HPTLC plates, thus in a 
planar system, and the detection of the different EAC with genetically modified yeast cells is 
performed directly on the plate. Employing pYES, therefore, provides the information of 
interest of a whole sample all at once. Additionally, the possibility for an identification of 
unknowns is realized by directly coupling HPTLC to MS. 
Without regard to the commonly used standard chromatographic methods, certain in vivo
and in vitro assays for the detection of EAC, including the planar yeast estrogen screen 
(pYES), are presented hereafter.
2.1.1 In vivo assays
In vivo methods provide information about the effects of compounds in organisms or the 
impact on their metabolism. For the detection of endocrine disruptors and EAC, a wide range 
of in vivo methods were developed and two of these methods – the rodent uterotrophic assay 
and the pubertal female rat assay – will be exemplarily explained.
The rodent uterotrophic assay is a method that is based on the uterotrophic response to 
estrogens. Present EAC cause a rapid growth of the uterus in immature or ovariectomized 
rats normally showing constant and low uterine weights [27]. The rats are treated – usually 
by oral gavage – with the test substances for three days, and 24 h after the last dose, the 
6uterus weight is determined and compared to reference values [27]. The test shows good 
reproducibility, but only slight uterine weight increases can lead to false positive results [27].
Another test is the pubertal female rat assay that is based on the detection of different 
changes in the organism caused by the test substance administered [28]. Pubertal female 
rats (22 days old, weaned at day 21) are treated for 20 days with the test substance and 
different endpoints are recorded, e.g. body weight, thyroid histology, uterine and ovarian 
weights and histology, vaginal cytology, and others [28]. The test thus provides a statement 
of the effects of the test substance on the pubertal development and thyroid function of the 
rat [28].
2.1.2 In vitro and cell-based assays
In contrast to in vivo assays, in vitro and cell-based methods do not consider the entire 
organism and effects on it, but certain substeps of functional chains, e.g. the binding of a
ligand by estrogen receptors (ER) [29]. Examples for in vitro assays for the detection of 
estrogenic activity are the ER-mediated chemically activated luciferase gene expression
assay (ER-CALUX) [30], the E-Screen (proliferation assay with MCF-7 breast cancer 
cells) [10] and the yeast estrogen screen (YES assay) [17].
In the course of the development of the ER-CALUX, luciferase reporter genes were 
implemented in different cell lines [30]. The implementation of the reporter gene in T47D 
human breast cancer cells expressing the ER provided highly responsive cell lines for the 
detection of (anti-)estrogenic activity of the test substances [30]. The test is based on the 
binding of present EAC by the ER, which is thus activated and subsequently binds to an 
estrogen-responsive element (ERE), resulting in transcriptions that lead to luciferase 
expression [30]. After addition of luciferin, the enzyme activity, and thus indirectly the 
estrogenic activity, is measured in a scintillation counter [30].
The E-Screen, in contrary, uses MCF-7 human breast cancer cells and investigates cell 
proliferation after exposure with the test substances or samples [10]. In presence of EAC, the 
proliferation of the MCF-7 cells is induced and an increase of the number of cells compared 
to a negative control (absence of EAC) is observed, i.e., the proliferation behavior is 
determined by means of measuring the cell yield [10].
Amongst available in vitro tests for estrogenic activity, particularly the yeast estrogen screen 
(YES assay) is to be mentioned. The assay is performed with yeast cells of a recombinant 
strain of Saccharomyces cerevisiae [17]. The yeasts are modified with a DNA sequence of 
the human estrogen receptor (hER) and the lacZ reporter gene that encodes for the enzyme
7E-galactosidase [17]. By binding of EAC, the hER is activated and subsequently binds to an 
ERE causing gene transcriptions that lead to the expression of the reporter gene and thus to
the production of E-galactosidase [17]. The glycosidic bond of the substrate chlorophenol red 
E-D-galactopyranoside (CPRG) is cleaved by the enzyme and releases chlorophenol red,
which subsequently is determined by absorbance, i.e., the estrogenic activity is measured 
indirectly via the enzymatic cleavage of a suitable substrate [17]. The YES assay is executed 
in aqueous solutions in microtiter plates, delivers results in 3–4 days, and provides a
statement about the total bioactivity of the samples (for example as equivalents of 17E-
estradiol), but neither the individual EAC nor their identities are determined. Since not only 
estrogenic but also anti-estrogenic effects or even toxicological effects of the entire sample
or sample extract are involved in the outcome of the assay, the result is obtained as total 
estrogenicity or rather as the sum of the biological activity of the components of a sample.
2.1.3 Planar yeast estrogen screen (pYES)
The transfer of the YES assay (see chapter 2.1.2) to a planar system was introduced by 
Müller et al. employing HPTLC plates silica gel 60 F254, and CPRG and 4-methylumbelliferyl-
E-D-galactopyranoside (MUG), respectively, as substrates [31]. The HPTLC-YES (planar 
YES, pYES) provides the option to determine EAC directly on the HPTLC plate. For that 
purpose, the test substances were applied onto the plate which was immersed in a yeast 
suspension of genetically modified yeast cells according to Routledge and Sumpter [17]
afterwards and subsequently was incubated [31]. Like in the microtiter plate YES assay 
described above, E-galactosidase is produced in consequence of the binding of EAC by the 
integrated hER and estrogenic activity was measured indirectly by means of the signal of the 
cleaved substrates in the respective HPTLC zones. The use of the fluorogenic substrate 
MUG, releasing blue fluorescent methylumbelliferone (MU) after enzymatic cleavage, 
increased the sensitivity of the screen by a factor of 20 compared to the chromogenic 
substrate CPRG releasing chlorophenol red [31]. Employing an HPTLC method usually 
provides the advantage to separate analytes due to their different properties in a planar 
chromatographic system and to see the single compounds of a sample after chromatography 
at one look. However, no separation of analytes by chromatography was performed in the 
work of Müller et al., and the duration of the test was at least 29 h [31].
Almost 10 years later, the planar YES as a combination of HPTLC and effect directed 
analysis for EAC on HPTLC silica gel plates with MUG as substrate was presented by 
Buchinger et al. [32], Spira et al. [33] (both worked with yeast cells generated by McDonnell 
8et al. [34,35], see below) and Schönborn and Grimmer [36] (yeast cells according to 
Routledge and Sumpter [17]). The mentioned studies demonstrated the separation and 
determination of EAC by pYES after 5 h. However, due to the aqueous conditions during 
pYES employing silica gel plates, the tests resulted in broadened and relatively diffuse 
HPTLC zones, complicating a quantitation. In 2017, Schönborn et al. presented a modified 
method for yeast cell application by a spray-on technique of cell suspensions onto the silica 
gel HPTLC plates instead of an immersion of the plates into the suspension, while, however, 
also the cell density was increased fivefold [37]. The spraying-on of the yeast suspension 
(yeast cells according to McDonnell et al. [34,35], see below) obviously led to sharper 
HPTLC zones and additionally lower limits of quantitation for the tested compounds 17E-
estradiol (E2), estrone (E1), 17D-ethinylestradiol (EE2) and estriol (E3) compared to former 
results and results presented for water-wettable reversed phase plates (HPTLC RP-18 W 
plates, see below), respectively. 
In 2014, however, Klingelhöfer and Morlock already modified the screening by using HPTLC 
RP-18 W plates, resulting in sharp-bounded, blue fluorescing zones of MU [38], using yeast 
cells according to McDonnell et al. [34,35]. McDonnell et al. generated a recombinant yeast 
strain of Saccharomyces cerevisiae by constructing an expression vector for the hER and 
integrating it in the yeasts [34]. Moreover, the yeast cells contain a so-called lacZ-CYC fusion 
reporter plasmid, composed of the yeast iso-1-cytochrome c proximal promoter elements and 
the structural gene (LacZ) for E-galactosidase from Escherichia coli [34,39,40]. In the course 
of chromatography, the components of a sample are separated on the HPTLC plate and are 
to be found in different HPTLC zones afterwards. EAC are bound by the implemented hER, 
causing the expression of the reporter gene and, therefore, the production of the enzyme E-
galactosidase, resulting in the enzymatic cleavage of the substrate MUG. Estrogenic activity
is then indicated through blue fluorescence of released MU in the HPTLC zones of present 
EAC.
During their experiments, Klingelhöfer and Morlock figured out the requirement of a pH 
adjustment of the RP-18 W plates since the plate material showed a low pH value of 4.8 [38],
and the activities of both yeast cells and enzyme are inter alia dependent on the current pH.
For yeast cell activity, the pH of 4.8 is suitable since optimal metabolism and growth of
yeasts are reported between pH 4.5 and 6.5 [41]. The optimal pH for the maximum activity of 
E-galactosidase, however, was reported at about 7.2 with enzyme stability between 6 and 8 
(E. coli, substrate o-nitrophenyl-E-D-galactoside) [42]. Therefore, Klingelhöfer and Morlock 
used a citrate buffer with a pH of 12 for the preparation of the MUG solution, resulting in a pH 
9of 7.2–7.4 on the plate surface after immersion in the substrate solution [38], which matched
the E-galactosidase pH optimum. Moreover, an additional stop solution for the termination of 
the substrate reaction with the same pH was applied [38]. MU has, however, a relatively high 
pKa of 7.8 [43] and would be present in its high fluorescent anionic form with only about 30% 
at a pH of 7.4. Since the fluorescence signals of MU obtained in the work of Klingelhöfer and 
Morlock are very intensive, however, the final pH of the plate is assumed being greater than 
7.4, presumably due to the high pH of the stop solution.
The application of the pYES developed by Klingelhöfer and Morlock with the reversed phase, 
water-wettable HPTLC plates on samples like beer, hops, waste water, river samples, 
propolis and spices, and the coupling to MS in order to identify unknown EAC was 
demonstrated [38,44–46]. The diverse samples were analyzed after extraction mostly without 
further purification steps and it has become apparent that many samples originally contain 
contaminants showing native fluorescences (blue, red) [45,46]. Blue fluorescing zones of 
sample components, however, might interfere with the determination of the estrogenic 
analytes when using the substrate MUG, since blue fluorescing MU is released as positive 
signal for estrogenic activity. To prevent false-positive conclusions, consequently negative 
controls had to be executed by performing the test without yeast cells [45,46]. By comparing 
negative controls and pYES results after substrate incubation with MUG, the differentiation of 
blue fluorescing zones due to native fluorescence and blue fluorescing zones due to 
estrogenic activity (enzymatically released MU) was possible [45,46]. Alternatively, the use of 
another substrate was suggested, e.g. the chromogenic substrate CPRG [46], releasing 
chlorophenol red after enzymatic cleavage.
Compared with the YES assay performed in microtiter plates, the pYES provides the 
detection and determination of single, separated EAC directly on the HPTLC plate, which is 
of high advantage. Consequently, anti-estrogenic and toxicological effects of other 
substances do most likely not disturb the determination of the substances of interest, since 
the single components occurring in the sample are separated from each other, and the EAC 
can thus be detected in single HPTLC zones. 
New developments in research in terms of the detection of endocrine disruptors with 
biosensors were recently presented by Chamas et al. (2017) [47,48]. Three modified yeast 
strains of Arxula adeninivorans were introduced, producing recombinant human estrogen, 
androgen and progestogen receptors, respectively, and additionally different reporter 
proteins showing differing fluorescences (blue, green, red) in response to the binding of 
10
respective ligands [47]. The simultaneous detection of estrogens, androgens and 
progestogens was successfully shown in microtiter plates after mixing the strains followed by 
the detection of the produced fluorescences at distinct wavelengths [47]. Additionally, the 
newly developed reporter assay was transferred to TLC (silica gel plates without 
fluorescence markers), allowing the separation and detection of the hormone activity of 
single substances of a sample [48]. The new three-channel bioassay, thus, provided the 
detection of the different sex hormones, while an additional step of substrate incubation 
(production of an enzyme which cleaves a suitable substrate resulting in a measurable signal 
as evidence for hormone activity) was no longer required [47,48].
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2.2 Estrogen active compounds
All the stated aspects and adverse effects of endocrine disrupting chemicals (EDC,
chapter 1) also hold true for EAC. These compounds can be natural or synthetic estrogens 
as well as xenoestrogens (natural or synthetic chemical substances with an estrogenic effect 
that occur in the environment or are used in consumer goods and other products). At natural 
estrogens, it is to be dealt with human estrogens or compounds like phytoestrogens, e.g. 
from soy [49–51] or hops [52]. Synthetic estrogens are substances used in pharmaceuticals, 
such as the estradiol receptor agonist 17D-ethinylestradiol that is used in contraceptives.
Xenoestrogens are, for example, mycotoxins like the Fusarium toxin zearalenone [53],
organochlorine pesticides like dichlorodiphenyltrichloroethane [54] or UV filter substances
used in cosmetics [18,19].
The principal targets of estrogens and EAC are the estrogen nuclear receptors ERD und ERE
[7]. Both receptors usually are located in different tissues but also can occur in the same 
tissue but in different cell types [55]. Mainly, ERD occurs in the ovary (theca cells), uterus, 
bone, breast, testes but also in the prostate (stroma), brain and white adipose tissue, while
ERE generally is to be found in the epithelium of the prostate, the granulosa cells of the 
ovary, testis, bone marrow, colon and also in the brain [55]. In ER-containing tissues of the 
body, EAC can be bound by the ER resulting in activation. The activated ER binds to ERE of 
the DNA, causing the transcription and therefore the production of target proteins, when 
mRNA is translated. Thus, EAC can impact various cellular processes in different tissues and 
sites of the endocrine system by binding to one of the receptors resulting in stimulation or 
inhibition of estrogen-responsive genes, which might lead to changes in the expression of 
other genes [7]. The effect of EAC is not only dependent on the receptors themselves, but 
also on the type of the ligand or different signaling pathways [7]. Therefore, the same ligand 
can have various effects by binding to different ER in distinct tissues [55], like the non-
steroidal anti-estrogen tamoxifen that is used in hormone-dependent breast cancer therapy. 
Tamoxifen acts as anti-estrogen in breast cells, while it showed estrogenic effects in 
experiments in old ovariectomized rats, when it stabilized body weight and reduced the loss 
of bone, albeit ovariectomized rats normally show osteoporotic symptoms due to the 
deficiency of estrogens [56].
Regarding the aquatic environment, some studies suggested that there is only a negligible 
risk of EAC exposure to humans through waters. However, EAC can accumulate in wildlife 
species, as presented in [57]. In the stated study, fish near a waste water treatment plant 
were analyzed, and showed increased levels of 17D-ethinylestradiol in the bile of fish 
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downstream compared to fish upstream the plant [57]. Larsson et al. therefore supposed 
EAC to be a health risk for humans due to their accumulation in fish and other predatory 
animals [57]. Additionally, it has been shown that EAC can have additive effects even if the 
single components are present in concentrations less than their no observable effect 
concentrations [58]. Similar observations in the course of their experiments were made by 
Sumpter and Jobling, when a mixture of weakly EAC resulted in a higher response than the 
sum of the responses of the single components [59].
Since estrogens and therefore also substances with estrogenic activity play a decisive role in 
human health, physiology and also in various diseases [55], the wide range of EAC with 
different structures and sources is of high concern. Estrogens are inter alia implicated in
breast tumors or disorders of the brain, but also in changes in the development, bones and 
the cardiovascular system [55]. The large variety, ubiquitous presence and additive effects of
EAC, and their impact on wildlife and humans is known and partly proved but cannot be 
estimated on the whole, and only a couple of examples of the following EAC classes 
i) human estrogens, ii) synthetic estrogens, iii) phytoestrogens and iv) xenoestrogens, and
their effects, will be thematized hereafter.
2.2.1 Human estrogens
The hormones 17E-estradiol (E2), estrone (E1) and estriol (E3) are human sex steroids and 
the most important natural estrogens. The chemical structures of E2, E1 and E3 are very 
similar and differ merely in their substituents at the sterane skeleton (Figure 2).
The biosynthesis of human estrogens from cholesterol is a tissue specific process, i.e., the 
different estrogens are synthesized at different sites of the human body [8]. E2 is synthesized 
in the ovary, whereas the synthesis of E1 takes place in the adipose tissue, and the 
synthesis of E3 in the placenta [8]. In non-pregnant, fertile women, E2 is the most important 
estrogen and additionally is the most potent of the endogenous estrogens [60]. In contrast, 
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Figure 2 Chemical structures of the natural human estrogens 17E-estradiol (E2), estrone (E1) and estriol (E3)
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E3 is mainly produced during pregnancy, whereas E1 is in metabolic equilibrium with E2 and 
moreover the predominant estrogen in postmenopausal women, when E2 synthesis 
decreases [60]. Estrogens are essential for various developments and mechanisms in both 
female and male [8]. They regulate important processes in the human body and influence, for 
example, the development and function of the female reproductive tract, the sperm transport, 
the endometrial development and tubal transport mechanisms [8]. Other target tissues of 
estrogens are the liver, the bones, the central nervous system, the cardiovascular system, 
and the skin [60].
When respective hormones are produced in insufficient amounts, disorders or afflictions can 
occur. Such a deprivation can thus be treated by hormone administration. The medical use of 
hormones is a long known and used therapy for different diseases or complaints. A common 
therapy, for example, is the treatment with estrogens and progestogens (gestagens, which
are also steroidal sex hormones) to decrease (post)menopausal complaints in elderly 
women, when the amount of endogenous hormones becomes insufficient [61].
2.2.2 Synthetic estrogens
Synthetic estrogens are substances that were developed and synthesized with the aim of
being estrogen active and that are used as active ingredients in contraceptives and other 
pharmaceuticals. Examples for synthetic estrogens are the steroidal substances 
17D-ethinylestradiol (EE2) and mestranol (a precursor of EE2), or the non-steroidal 
diethylstilbestrol (DES).
Like the natural estrogen E2, the synthetic estrogen EE2 shows activity at estrogen receptors 
and is therefore used in contraceptives as ER agonist. Structurally, EE2 is similar to E2, and 
likewise shows the sterane skeleton such as the natural hormone, however, also shows an 
additional ethinyl group as substituent at C-17 (Figure 3).
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Figure 3 Chemical structure of 17D-ethinylestradiol (EE2)
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EE2 was developed to be active as ER agonist in humans for contraception, but it has been 
observed to also have an impact on wildlife species. After the finding of hermaphrodite fish in 
lagoons of waste water treatment plants, it was assumed that sewage and substances like 
EE2 occurring in the waste water caused the physiological disturbances in local fish, why
tests for vitellogenin production in fish were executed [62]. Vitellogenin is a precursor protein 
normally produced in maturing female fish induced by estrogens and is used as biomarker 
for EAC [59]. The possibility for an evidence of estrogenic contamination via the vitellogenin 
production is given since the content of vitellogenin in male fish is very low or vitellogenin is 
not present at all [63]. However, vitellogenin production in male fish can be induced by 
EAC [59]. Therefore, rainbow trout were exposed to EE2 by injection or immersion in EE2-
containing water, and vitellogenesis was investigated [62]. The experiments showed the 
induction of vitellogenin production and thus estrogenic activity of EE2 even at low 
concentrations of 0.1 ng/L in the test water [62]. Therefore, EE2 was proven to be a very 
potent EAC in fish [62].
A further study investigated the effects of EE2 (mean of ~6 ng/L) on wild fathead minnows in 
test lakes compared to fish from reference lakes (no addition of EE2) over several years,
when vitellogenin production in male and also an increased vitellogenesis in female fish were
observed [64]. The production of vitellogenin in female fish collected in the non-active 
vitellogenic stage in fall did, moreover, not really decrease whereas vitellogenesis in female 
fish from the reference lakes declined [64]. Changes in liver cells and abnormalities in the 
kidneys in both male and female fish were also observed [64]. Moreover, male fish showed 
fibrosis and feminization, and the development of the testicular tissue was interfered [64,65].
In addition, abnormalities like a modified oogenesis were also observable in female 
fish [64,65]. All the stated aspects led to a population collapse, whereby inter alia also the 
short life cycle of fathead minnows was supposed to be a relevant factor [64,65].
Studies on sand gobies in Scotland also showed the influence of EE2 on a fish population, 
when sand gobies were exposed in a flow-through experiment to water containing EE2 
(6 ng/L), resulting in reduced reproductive success and elevated vitellogenin levels [66].
Similar experiments were executed in Finland, when male sand gobies were exposed to EE2 
(5 and 24 ng/L) and the effects on the sexual selection and the mating system but also 
physiological effects via the biomarkers vitellogenin and zona radiate protein (an eggshell 
protein) were investigated [67]. The studies showed a disrupted sexual selection most likely 
caused by the behavior of male fish and it was assumed that an increased period of 
exposure would lead to the loss or reduction of secondary sexual characters and therefore to 
reproduction problems for the population [67]. The studies also showed effects on the 
behavior of male fish at low concentrations of EE2 (5 ng/L) at which no production of 
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vitellogenin or zona radiate protein was induced, why the authors pointed out that these 
biomarkers should not be the only monitored parameters at investigations of the reproductive 
behavior [67].
A further synthetic chemical produced for contraceptives is mestranol, which, however, is 
inactive as estrogen but is a precursor of estrogen active EE2 and also shows structural 
similarity to E2 (Figure 4). 
Mestranol was used in combined compounds for contraception. As prodrug of EE2, 
mestranol has to be transformed into the estrogen active form of EE2 in vivo by 
demethylation in the liver [68]. Due to variable conversion in the body, however, the actual 
amount of active EE2 cannot be estimated, why mestranol usually is not used in 
contraceptives anymore [68].
Although the compound diethylstilbestrol (DES, Figure 5) does not show clear structural 
similarities to E2 or other natural steroidal estrogens, the substance shows estrogenic 
activity. 
DES is a non-steroidal synthetic estrogen that was developed in the 1930s, and was used 
back in the 1940s until the beginning of the 1970s in pregnant women to prevent 
spontaneous abortions and other pregnancy complications [20]. In the early 1970s, however, 
studies revealed that about 60% of in utero to DES exposed women, thus daughters of DES-
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Figure 5 Chemical structure of diethylstilbestrol (DES)
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treated pregnant women, showed structural changes or abnormalities in their reproductive 
organs in adulthood [69]. Additionally, DES did not only impact in utero exposed female 
offspring but also in utero exposed sons. It has been observed that men exposed to DES in 
utero showed crucially more often genital malformations than non-exposed men [70]. These 
observations were made twice as often in male offspring that were exposed to DES in the 
first 11 weeks of pregnancy compared to men exposed later in gestation [70]. Therefore, a 
higher risk for a diagnosis of genital malformations in men, who were exposed to DES during 
early pregnancy, was assumed [70]. Other effects such as infertility of the exposed sons 
were not observed [70].
2.2.3 Phytoestrogens
Alongside endogenous estrogens or pharmaceutical treatments, an exposure to EAC can 
occur through further routes. Other natural sources for EAC are plants containing 
phytoestrogens, when an exposure can take place, for example, through diet or by direct 
contact. As to be seen hereafter, the discussed phytoestrogens also do not show clear 
structural similarities to the natural human hormones. Nevertheless, their estrogenic activity 
is proven.
It was reported, for example, that women, who harvested hops by hand, suffered from
disturbances in their menstrual cycle [71]. At first, the prenylchalcone xanthohumol (XN), the 
most abundant hop flavonoid [72], was assumed to be responsible for the estrogenic 
properties of hops [71]. Later studies, however, revealed 8-prenylnaringenin (8-PN, Figure 6)
to be a potent phytoestrogen and the hop flavanones 6-prenylnaringenin (6-PN, Figure 6), 
6,8-diprenylnaringenin and 8-geranylnaringenin to be further hop compounds showing 
estrogenic activity [52,73].
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Figure 6 Chemical structures of the prenylated hop flavanones 8-prenylnaringenin (8-PN) and 6-
prenylnaringenin (6-PN)
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During the brewing process of beer, the major hop flavonoid XN can be transformed to 
isoxanthohumol (IXN), and also the formation of the estrogen active prenylated hop 
flavanones 6-PN and 8-PN from the isobaric estrogen inactive desmethylxanthohumol was 
reported [74,75], why more prenylflavanones than prenylchalcones are present in beer [76].
IXN was determined as major prenylflavonoid in beer [76] and represents a so-called 
proestrogen, i.e., IXN can be converted into 8-PN by specific intestinal microbiota in humans,
which leads to a probably higher exposure to EAC than be expected after an analysis of beer 
samples [77,78].
Further phytoestrogens can be found in various plant species, for example in some strains of 
clover [79] or in soy beans [49,50]. Clover species contain isoflavones such as genistein and 
biochanin A, but also formononetin that can intestinally be transformed into the estrogenic 
active isoflavan equol [79]. The estrogenic activity of compounds from strains of 
subterranean clover was detected at the end of the 1940s, when sheep (ewes) grazing on 
clover-rich areas in Western Australia suffered from infertility due to estrogenic clover
isoflavones [79]. Shortly after these observations, experiments with ovariectomized sheep 
were executed [80]. Ovariectomized sheep usually show an atrophy of the uterus, which can 
be treated by estrogen administration therapies, i.e., uterus atrophy can be restored by 
treatment with estrogens [80]. To consider whether a clover-rich diet will have equal effects 
on ewes, ovariectomized sheep were divided in two groups, one of which was held on an 
area dominated by clover, and the other group on a control pasture without clover, and the 
sheep were examined in certain intervals [80]. During periods of growing green clover, the 
animals of the group on the clover-rich field did not show effects upon ovariectomy, while the 
animals of the control group showed changes of the uterus [80]. In times when clover wilted, 
however, an atrophy of the uterus was observable in both groups [80]. The possible 
restoration of the normal uterus state after atrophy by grazing on green clover pastures in the 
following season was also observed [80]. These experiments thus proved the estrogenic 
potential of clover. 
Exposure to phytoestrogens from clover is an important topic in respect of grazing animals, 
but plays a minor part for human diet, whereas exposure to phytoestrogens from soy is of
higher interest, especially because the consumption of soy proteins and soy-based foods in 
the western population steadily increases. Vegetarians or vegans ought to ingest protein 
from alternative sources, e.g. in the form of soy products. Besides, a lot of formulas for 
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infants are soy-based [49,81], and due to the higher sensitivity of fetuses and infants, an 
exposure to phytoestrogens from soy is of concern. 
The major isoflavone in the soy bean is genistein (Figure 7) [50]. An investigation of multiple 
soy-based infant formulas at the end of the 1990s showed high contents of isoflavones in 
these products, mostly occurring as glycosidic conjugates, when genistein was determined 
as major isoflavone component [49].
Moreover, the concentration of the isoflavones in the plasma of four month old infants fed 
with soy-based infant formulas was determined, showing higher concentrations than in 
infants fed with cow-milk formulas or human breast milk [49]. The daily plasma 
concentrations were comparable to those found in adults ingesting a moderate amount of 
soy-containing food [49]. Such high plasma concentrations in infants allow the assumption of 
a high absorption and thus a high bioavailability of the isoflavones [81]. Experiments for the 
binding of soy isoflavones by estrogen receptors resulted in the confirmation that genistein is 
bound by the ER [50]. Furthermore, genistein was proven to be estrogen active in vivo, and 
to be an estrogenic development toxicant and an estrogenic carcinogen in rodents [50]. In 
another study, neonatal female mice were exposed to genistein on their first five days of life, 
resulting in an increased uterine weight after 5 days and also in abnormalities (uterine 
adenocarcinoma) in 18 month old mice [51]. These studies led to the assumption that 
genistein is also relevant in humans [50], especially when exposure to genistein occurs in 
utero or during early development. Particularly, a prenatal exposure may be of higher 
concern since other EAC such as DES showed effects on the offspring after in utero
exposure (see chapter 2.2.2), why a soy-rich diet of the mother might cause problems for the 
offspring [81].
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Figure 7 Chemical structure of genistein
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2.2.4 Xenoestrogens
Xenoestrogens are estrogen active natural or synthetic chemical substances that are used in 
products or occur in our environment. The estrogenic activity of xenoestrogens, however, 
cannot be predicted by means of the chemical structures of these substances, since the 
structures are dissimilar from the natural steroidal estrogens and also differ strongly from 
each other, as become clear below.
Natural xenoestrogens are – as separate group differentiated from phytoestrogens –
substances from natural sources, showing estrogenic activity and occurring in the 
environment such as mycotoxins. The growth of mycotoxin producing fungi on cereal grains 
can cause problems for animal and human health, for instance resulting in reproductive and 
feeding disturbances in livestock cultivation [82]. The Fusarium toxin zearalenone (Figure 8)
and some of its derivatives were proven to be mycoestrogens showing uterotrophic activity in 
mice [53].
Zearalenone, thus, might have an impact on humans and livestock nutrition since the 
mycotoxin producing fungi distribute on plants (crops) that are used for food and feed [83].
Caldwell et al. investigated the zearalenone production of different Fusarium species that 
were grown on autoclaved corn, and subsequently the respective ethanol extracts of the corn 
were tested for estrogenicity [83]. The experiments showed estrogenic activity of ethanol 
extracts of corn infected with Fusarium graminearum and of isolates of F. tricinctum, verified 
by uterine weight in a mouse bioassay [83]. Different effects to human and livestock health 
and various diseases due to mycotoxins and mycotoxin contaminated foods, respectively, 
are reported [84]. It was observed that zearalenone, which can be detected in cereals and 
products of cereals, was responsible for hyperestrogenism in pig that were fed with moldy 
grain, but it is also blamed for causing premature puberty in girls and for being responsible 
for cervical cancer [84]. Some studies supposed zearalenone-contaminated food as a 
minimal risk for human health [84], however, zearalenone might not be the only 
xenoestrogen exposure, and an exposure to mixtures of xenoestrogens might show 
O
OOH
OH
CH3
O
Figure 8 Chemical structure of zearalenone
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estrogenic effects even when the concentrations of individual EAC do not cause any effects
[58]. Moreover, researchers in Hungary investigated patients with early breast development 
(telarche) and their diet, showing the presence of zearalenone both in the food and in serum 
samples of 14% of the patients, why a connection between contaminated food and early 
telarche in sensitive individuals due to chronic exposure was concluded [85].
Alongside natural xenoestrogens, wildlife and humans also can be exposed to synthetic 
xenoestrogens from a number of sources. At this, synthetic xenoestrogens comprise a wide 
range of structurally heterogeneous substances and are used, for example, in consumer 
products, industry or agriculture. The substances were not designed or are not used, 
respectively, with the aim of being estrogen active and thus to affect ecosystems or the 
health of humans. Examples for synthetic xenoestrogens are the plastic additive bisphenol A
(BPA), pesticides such as dichlorodiphenyltrichloroethane (DDT), alkylphenolic compounds, 
UV filters and others. Environmental aspects, the occurrence and the effects of some 
synthetic xenoestrogens will be addressed below. 
The pollution of waters with EAC over the whole world is reported and is steadily influenced,
since EAC find their way to waters via landfills or waste water treatment plants but also due 
to environmental pollution. Thus, many studies are concerned with the impact of effluents 
from sewage treatment plants on aquatic organisms as described for EE2 earlier in this work 
(chapter 2.2.2). Studies in England and Wales, for instance, showed an increased 
vitellogenesis in female fish but especially high concentrations of vitellogenin in male fish 
exposed to the effluent of a waste water treatment plant and also in fish placed at sites of a 
river near the inflow of the effluent, demonstrating estrogenic contamination of sewage and 
water bodies [59,62].
Environmental pollution, however, not only affects aquatic systems and organisms but also 
other wildlife species. The impact of the insecticide DDT (Figure 9) on gull embryos, for 
example, was investigated by treatment of uncontaminated eggs with DDT and metabolites 
of DDT in levels measured in contaminated eggs in the 1970s [54]. It was observed that the 
treatment led to a feminization of male gulls and also to changes in the development of 
female embryos [54].
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In another study, DDT was injected in the yolk of eggs of domestic hens in amounts reported 
for eggs of wild birds, and after hatching, the hens were raised to adult age [86]. The 
experiments showed that the eggshells of the eggs of the hens exposed during embryonic 
development were significantly thinner than the eggshells of eggs of control hens, concluding 
that DDT exposure causes eggshell thinning [86]. Additionally, Holm et al. pointed out that 
eggs of wild birds also are subjected to further estrogenic exposure by various EAC 
occurring in the environment, possibly resulting in additional effects and thus in further 
alterations caused by endocrine disruption [86]. Moreover, a connection between the 
development of a declined population of brown pelicans and the DDT pollution in California 
around the year 1970 was presumed [87]. With a decreasing environmental concentration of 
DDT and its metabolites, the amount of DDT and its metabolites in anchovies – the main 
food of brown pelicans – decreased also, and as a consequence a recovery of the population 
of brown pelicans was observable [87].
The usage of DDT was limited or restricted in the 1970s in the United States of America 
(USA) and many other countries due to various concerns for the environment, wildlife and 
humans [88]. In 2001, the use of DDT was regulated with the Stockholm Convention on 
Persistent Organic Pollutants, which is a global treaty that came into effect in 2004 and was 
adopted to the European Union (EU) with the European Regulation No 850/2004/EC [89].
Thus, the use of DDT is constrained on malaria control [89]. However, since DDT and its 
metabolites are very persistent and accumulate in the environment and organisms, DDT is
still of interest and importance today [88].
An exposure with xenoestrogens can take place through various routes, for example via
EAC-containing products and materials or via the formation of EAC as breakdown products 
from non-estrogenic predecessors. Thus, xenoestrogens does not only concern the aquatic 
environment or wildlife species. An example to be mentioned is the uptake of estrogen active 
UV filter substances by the skin [90] or the food chain (accumulation in fish [91],
accumulation in human breast milk [92]). Moreover, several studies revealed the leaching of 
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Figure 9 Chemical structure of dichlorodiphenyltrichloroethane (DDT)
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EAC from plastics or the accumulation of estrogen active degradation products from 
chemicals and the presence of these substances in food [93–95].
BPA (Figure 10), for example, is an EAC that is used as monomer for the production of 
polycarbonate and that is also present in epoxy resins used as coating in food cans [96].
Alongside the usage of polycarbonate for various plastic items, it is inter alia used for food 
contact materials (drinking bottles, cookware) [96], wherefore a possible leaching of BPA into 
food is a relevant topic. Thus, employing calculated exposure rates, food was revealed as 
the major source of BPA exposure [96].
Moreover, plastics most likely end up on landfills where critical substances can find their way 
into the environment, for example into leachates. Studies in Japan detected estrogenic 
activity of leachates and groundwater at a sea-based landfill [97]. The groundwater showed a 
high concentration of BPA that might have leached from plastic waste at the landfill and that
was assumed to cause most of the determined estrogenicity (estimated contribution rate of 
84%) [98]. Similar results have been obtained in the USA, when raw leachates of landfills 
were examined and showed estrogenicity, whereas the present BPA concentration was 
assumed to be sufficient and thus to be responsible for the observed effect [99]. Additionally, 
the leaching of estrogen active BPA from polycarbonate plastic tubes used in laboratory
experiments by Krishnan et al. was detected, when the real objective actually was to 
determine the estrogenic activity produced by a yeast strain of S. cerevisiae [93].
Further xenoestrogens to be mentioned are alkylphenols. Alkylphenols (AP) are used, for 
example, as plastic additives [94], or as part of the production of aromatic substances 
(flavors, fragrances) [100]. AP, however, do more likely occur in the environment as 
breakdown products from alkylphenol polyethoxylates (APEO) used in many formulations 
such as plant protection agents (pesticides, herbicides), detergents, paints, and hair-care 
products [16,100]. APEO are used, for example, as nonionic surfactants in cleaning products
and often end up in the aquatic environment [16]. Their degradation products are the 
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Figure 10 Chemical structure of bisphenol A (BPA)
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corresponding AP, mainly 4-nonylphenol (NP, Figure 11) and 4-octylphenol (OP, Figure 11),
which particularly accumulate in sludge due to their hydrophobic properties [16]. Thus, NP is 
a degradation product from nonylphenol ethoxylates (NPE) used in disinfectants and in 
pesticides as emulsifiers [94,95].
It is proven that AP are bound by the ER, and that AP can displace bound estradiol or 
prevent the binding of estradiol by the ER [101]. White et al. investigated the estrogenicity of 
environmentally relevant AP, while both NP and OP showed estrogenic activity in different 
assays, inter alia in studies with human breast cancer cells (MCF-7) and in an estimation of 
the vitellogenin production in hepatocytes from male rainbow trout using a
radioimmunoassay [16]. Moreover, it has been confirmed that the activity is based on the 
binding by the ER, and in experiments with OP it has been shown that AP are active as 
estradiol mimics [16]. The estrogenic potency of surfactants and their breakdown products 
was also investigated by Routledge and Sumpter using a yeast estrogen screen (YES) [17]
(see chapter 2.1.2). In these studies, none of the tested surfactants showed estrogenic 
activity, but some of the possible alkylphenolic degradation products were detected to be 
weak EAC [17]. In further studies employing the YES assay, Routledge and Sumpter figured 
out the dependence of the estrogenic activity of AP on the degree of branching in the alkyl 
chain, the alkyl chain length and the position of the alkyl chain [100].
As mentioned above, APEO and AP are applied in different areas, not only affecting products 
that might end up in the aquatic environment, but also in products with possibly direct contact 
to humans what might result in adverse effects on human health. NP, for example, was 
identified as estrogenic substance leaching from centrifuge tubes made of modified 
polystyrene by Soto et al. [94]. Additionally, NP also was reported to be ubiquitous in food, 
while contamination via different pathways is possible and varying concentrations were 
determined in different foodstuffs, independent of the fat content and the packaging of the 
food [95].
The manufacture and placing on the market of NP and NPE are regulated in the EU by 
Regulation No 1907/2006/EC [102]. This so-called REACH Regulation (Registration, 
Evaluation, Authorisation and Restriction of Chemicals) restricts the usage and placing to the 
market of NP and NPE as single substances or in mixtures to an amount of at most 0.1% by 
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Figure 11 Chemical structures of 4-nonylphenol (NP) and 4-octylphenol (OP)
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weight, valid for specific products and purposes given in Annex XVII of this regulation, 
including cosmetics, personal care products and different kinds of cleaning processes [102].
Despite this regulation, NP is still found in the environment and therefore needs further 
attention.
Other critical substances with estrogenic potential are organic filter substances used in UV 
screens and other cosmetics or technical products. These chemicals are allowed to be 
added to cosmetic products [103], on the one hand to sun screens for skin protection (main 
usage), on the other hand in order to protect further ingredients of the cosmetic products 
against UV radiation. Since cosmetics usually have direct contact to the human skin and UV 
filter substances could accumulate in human and wildlife due their relatively high lipophilicity, 
the estrogenic activity of these substances is of concern.
The organic UV filters benzophenone-3 (Figure 12) and octyl methoxycinnamate (Figure 12), 
for example, were detected in human breast milk from 5 of 6 tested mothers in Germany in 
the 1990s, indicating accumulation of these chemicals in the adipose tissue [92].
Moreover, in the years of 1991 and 1993, up to six different UV filter substances were 
detected in fish (European perch and roach) of the Meerfelder Maar (maar in the Eifel in the 
West of Germany), including benzophenone-3, octyl methoxycinnamate and 4-
methylbenzylidene camphor (Figure 13) [91]. The water of this maar was also investigated, 
however, only in one year a single substance was detectable, why a high bioaccumulation of 
these substances in fish was concluded [91]. Since the maar is commonly used as lake for 
bathing, the bathers were the most likely reason for the contamination and the subsequent 
accumulation of the UV filters in fish [91].
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Figure 12 Chemical structures of benzophenone-3 and octyl methoxycinnamate
O
Figure 13 Chemical structure of 4-methylbenzylidene camphor
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Studies on the estrogenicity of 6 UV filter substances were executed in an in vitro assay (E-
Screen with MCF-7 breast cancer cells) and in vivo with an uterotrophic assay [18]. The in 
vitro test showed estrogenic activity of 5 of 6 compounds tested, including benzophenone-3,
octyl methoxycinnamate and 4-methylbenzylidene camphor [18], which are two of the UV
filters detected in human breast milk [92] and three of the UV filters detected in fish [91].
These three UV filters also showed an increased uterine weight in the uterotrophic assay in 
the immature rat after oral administration, indicating in vivo estrogenicity [18]. However, it 
was pointed out that it is uncertain whether the compounds themselves or possible 
metabolites caused the effects observed [18]. Despite their in vivo and in vitro estrogenicity, 
the mentioned UV filters are allowed for usage in cosmetic products, regulated by the EU in 
Regulation No 1223/2009/EC [103]. In the ready to use preparation, benzophenone-3 and 
octyl methoxycinnamate are allowed up to a maximum concentration of 10%, and 4-
methylbenzylidene camphor up to 4% [103]. Experiments by Janjua et al. demonstrated, 
moreover, the dermal adsorption of the UV filters benzophenone-3, octyl methoxycinnamate 
and 4-methylbenzylidene camphor, which were all found in plasma and urine samples, when 
postmenstrual women and young men were exposed with lotion (topical administration)
containing all three of these substances [90]. Additionally, reproductive hormone levels were 
investigated but no effects were observed [90]. Despite these observations, it has to be in 
mind that the same exposure might affect the endocrine system of children, since children 
have lower levels of endogenous hormones and also the elimination way for drugs is not as 
developed as in adults, why their endocrine system can be disrupted easier [90].
Last but not least, parabens (Figure 14), i.e., parahydroxybenzoates or esters of 
parahydroxybenzoic acid, shall be mentioned as example for widely used substances 
showing estrogenic activity. 
Parabens show alkyl chain length dependent antimicrobial activity [104], and are used as 
preservatives in cosmetics and food, and also in medication, thus resulting in direct exposure 
to humans. Maximum concentrations for the use in cosmetic products are given in 
Regulation No 1223/2009/EC of the European Parliament and the Council [103]. In the ready 
to use preparations, 4-hydroxybenzoic acid and its salts and esters (methyl, ethyl, propyl, 
butyl) are allowed with a maximum concentration of 0.4% (as acid) for single esters and 
OH
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Figure 14 Chemical structure of parabens (R = alkyl group)
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0.8% (as acid) for mixtures of esters, respectively [103]. Ethyl and methyl derivatives of 
parahydroxybenzoic acid are, moreover, allowed as food additives with varying maximum 
levels according to respectively specified food categories, regulated by Regulation 
No 1333/2008/EC on food additives [105]. In a work by Routledge et al. [104], different 
parabens were tested for estrogenicity using a YES assay according to [17]. Methyl, ethyl, 
propyl and butyl derivatives all showed estrogenic activity in the YES assay, whereas 
parahydroxybenzoic acid, which is the parent substance of the mentioned derivatives and 
their main metabolite, was inactive [104]. The estrogenicity increased with the alkyl chain 
length, and the methyl and butyl esters were additionally tested in two different in vivo tests 
(uterotrophic assays in rats) [104]. After subcutaneous injection, methyl paraben did not 
increase the uterus weight, whereas butyl paraben led to an uterotrophic response [104].
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2.3 Brief summary on EAC
The preceded sections gave an overview of the broad spectrum of substances showing 
estrogenic activity, the possible ways for an exposure to EAC, and their effects. It becomes 
apparent that estrogenicity is not limited to natural hormones or substances with structural 
similarities to these, but that EAC are structurally very heterogeneous and an exposure 
through many different routes is possible. 
Therefore, an environmental monitoring in terms of EAC, especially a monitoring of the 
aquatic system, is meaningful in order to estimate current estrogenic load or, for example, to 
verify the efficiency of waste water treatment. Apart from environmental aspects, nowadays, 
there is also an increasing interest in products that not contain consciously added 
substances identified to be estrogenic or endocrine active such as parabens in cosmetics, 
what frequently is also highlighted in product advertisements. 
For a monitoring, different tests are available, including various in vivo and in vitro tests 
indicating estrogenic activity. Standard chromatographic methods, moreover, can be used for
the determination of specific substances with known endocrine disrupting properties. The 
planar yeast estrogen screen provides, however, the separation, detection and determination 
of individual components, including an evidence of estrogenic activity, in a single test. And 
therefore, the pYES is a very suitable tool for environmental samples to monitor whether the 
samples contain estrogenic compounds, and additionally to identify and quantify these 
substances.
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3 Legislative aspects in respect of waters (European Union)
Considering the chemical load of the aquatic environment due to emission of hazardous 
substances, and thus health and population risks especially for aquatic organisms, and in 
respect of the reduction of the pollution, the European Commission worked out different 
legislations. The EU Water Framework Directive (Directive 2000/60/EC), which is the main 
water policy instrument for setting antipollution strategies, amended by the decision and 
directives given in [106–108], orders the member states to conduct necessary steps to 
progressively reduce the pollution by priority substances and to (stepwise) terminate 
emissions, discharge and loss of these substances [109]. In this regard, priority substances 
are substances that cause a high risk for or via the aquatic environment. Thus, Directive
2008/105/EC (amended by Directive 2013/39/EU [108]) lists environmental quality standards 
(EQS) for pollutants classified as priority substances according to the Water Framework 
Directive [109], primarily for inland and other surface waters, but due to the potential of an 
accumulation also sediments and biota ought to be under investigation [107]. The list of 
priority substances in the field of water policy is given in Annex X of Directive 2000/60/EC, 
and indicates inter alia nonyl- and octylphenols, while nonylphenols are stated as identified 
priority hazardous substances [107–109]. Annex I of Directive 2008/105/EC lists the EQS of 
the priority substances and certain other pollutants with maximum allowable concentrations 
in inland and other surface waters, but also in biota, where biota means fish if not otherwise 
indicated [107,108]. Amongst 45 substances or substance groups, this list includes DDT, NP 
and OP (4-tert-OP) [108]. Article 8b of Directive 2008/105/EC implies to the Commission to 
create a watch list of substances that are likely to be a considerable risk to or via the aquatic 
environment and that should be monitored due to the lack of monitoring data in order to
support future processes of prioritization [107]. The list comprises 10 substances or groups 
of substances, the respective matrices and also analytical methods for the determination of
the substances or groups of substances with respective maximum acceptable method 
detection limits, implemented by the Commission Implementing Decision 2015/495/EU [110].
The watch list inter alia includes the natural estrogens E2 and E1, the synthetic estrogen 
EE2 and the estrogen active UV filter 2-ethylhexyl-4-methoxycinnamate (octyl 
methoxycinnamate) [110]. Maximum acceptable detection limits for the natural and synthetic 
estrogens are 0.4 ng/L for both E2 and E1 and 0.035 ng/L for EE2, while the analytical 
methods indicated are large-volume solid phase extraction (SPE) followed by liquid 
chromatography tandem mass spectrometry (LC-MS-MS) for EE2 and SPE–LC-MS-MS for 
both E2 and E1 [110]. The method indicated for octyl methoxycinnamate is SPE–LC-MS-MS
or gas chromatography MS with a maximum acceptable detection limit of 6000 ng/L [110].
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4 Scope and aims of this work
Regarding the ubiquitous presence of EAC in our environment and especially the risks for 
wildlife and humans, and with respect to the watch list of the Implementing Decision of the 
European Commission, it is of great importance to monitor EAC in environmental samples. 
The aim of his work was to develop a planar yeast estrogen screen (pYES, or high-
performance thin-layer chromatography-planar yeast estrogen screen, HPTLC-pYES) as a 
screening for EAC in water and sewage samples. The pursued objective was the 
development of a method that allow a bioautography for EAC after prior chromatography 
directly on the HPTLC plate employing the recombinant yeast strain generated by 
McDonnell et al. [34,35]. The yeasts contain the human estrogen receptor and the LacZ
reporter gene encoding for the enzyme E-galactosidase [34,35]. Since many environmental 
samples contain components showing native fluorescences (blue, red), the detection of blue 
fluorescing methylumbelliferone, which is enzymatically released from the generally used 
substrate 4-methylumbelliferyl-E-D-galactopyranoside, can be interfered. It was purposed to 
introduce a substrate, which allows the differentiation of native fluorescences and positive 
pYES-signals caused by estrogenic activity. Additionally, it had to be verified, whether
HPTLC simultaneously represents a planar clean-up since environmental samples are 
commonly highly polluted, thus often require complex extraction and purification steps such 
as a solid phase extraction (SPE). 
Furthermore, the pYES to be developed should enable the quantitation of EAC and the 
identification of unknown EAC by means of coupling HPTLC to mass spectrometry. In 
addition, the application of pYES on further samples should be tested, e.g. on food samples.
Since receptor assays such as the pYES usually show a saturation behavior (exemplarily 
shown for the YES assay in [17,111]), i.e., provide sigmoidal dose-response curves on a 
logarithmical scale, a logit-log evaluation of pYES ought to be possible. Therefore, another 
objective was to proof this assumption and to transfer the logit-log method as evaluation tool 
to pYES (normally used in microtiter plate assays such as radioimmunoassays and enzyme-
linked immunosorbent assays [112–115]). Dose-response curves additionally will allow the 
determination of half maximal effect doses (ED50) [33] and therefore the determination of 
estradiol equivalent factors (EEF) of known EAC, and the estradiol equivalent concentration 
(EEQ) or estradiol equivalent amount (EEA) of known and unknown EAC in liquid or solid 
samples.
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a b s t r a c t
For the planar yeast estrogen screen (pYES), 4-methylumbelliferyl-b-d-galactopyranoside was generally
employed as substrate, delivering blue fluorescing 4-methylumbelliferone after enzymatic cleavage by
the YES reporter b-d-galactosidase as the positive signal for the presence of estrogen active compounds
(EAC). As environmental samples likewastewater also contain blue fluorescent components, it is difficult
to differentiate them frompYES signals. Therefore, resorufin-b-d-galactopyranoside (RGP), providing the
orange fluorescing resorufin after enzymatic cleavage, was introduced as pYES substrate to determine
EAC.With 17b-estradiol (E2) and17a-ethinylestradiol (EE2),mean limits of detection andquantitation of
3.5 and 6.5pg/zone, respectively, were determined. Obtained recoveries for both E2 and EE2 from spiked
water samples in a concentration range of 2–20ng/L were close to 100%. The application of the RGP-pYES
on waste water influent and effluent samples showed the clear detection of EAC without interferences.
Estrone (E1), Estriol, E2, and an unknown EAC were found in the influent sample (E2 with a mean of
16.9 ng/L and a precision of 11% RSD; n=4), while another unknown EAC was observed in the effluent
sample. In addition, the presence of conjugated EAC in the influent was demonstrated by hydrolysis with
b-glucuronidase,when the signals of E1 and the unknown increased by about 25% and 100%, respectively.
© 2017 Elsevier B.V. All rights reserved.
1. Introduction
The European Commission published an implementing decision
[1] to establish a watch list of substances for Union-wide monitor-
ing in the field of water policy according to a preceding directive
[2,3]. The monitoring shall help to identify the actual risk posed by
the listed substances. This watch list includes the estrogen active
compounds (EAC) 17a-ethinylestradiol (EE2), 17b-estradiol (E2)
and estrone (E1). In addition, possible suitable methods of analysis
including maximum acceptable detection limits are listed. Method
detection limits should be at least as low as the presumable no-
effect concentrationof each substance and shouldbe loweredwhen
new information shows a decrease of the no-effect concentration.
According to the implementing decision of March 2015 [1], the
maximum acceptable method detection limits are listed as fol-
lows: 0.4ng/L for E2 and E1, and 0.035ng/L for EE2. The indicated
methods include a solid-phase extraction and a large volume solid-
phase extraction for E2/E1 and EE2, respectively, followed by liquid
chromatography-tandemmass spectrometry.
∗ Corresponding author.
E-mail address: wolfgang.schwack@uni-hohenheim.de (W. Schwack).
In the field of trace analysis of EAC, different in vitro meth-
ods has gained great importance, like the yeast estrogen screen
(YES) [4], the estrogen responsive chemical activated luciferase
gene expression assay (ER-CALUX) [5], or the estrogen screen (E-
screen) [6], which are performed in microtiter plates. The YES
assay was also successfully combined with planar chromatogra-
phy (planar YES, pYES) providing a chromatographic separation of
samples by high-performance thin-layer chromatography (HPTLC)
prior to bio-detection by the yeast cells [7–12]. Initially, pYES
was performed on normal phase silica HPTLC plates resulting in
broadened zones after humid incubations, which were difficult or
impossible to quantify [7–9]. This problem was solved by applica-
tion of water-wettable reversed phase plates (RP–18W) providing
sharp-bounded zones, even after prolonged incubation in anhumid
atmosphere [10]. Different applications of the method proved
the progress [11,12]. The generally used substrate for pYES was
4-methylumbelliferyl-b-d-galactopyranoside (MUG) that deliv-
ers blue fluorescing 4-methylumbelliferone (MU) after enzymatic
cleavage by the YES reporter b-d-galactosidase as the positive sig-
nal for the presence of an EAC in an HPTLC zone. However, many
environmental samples, like influents or effluents of waste water
treatmentplants, porewaterof sediments, andeven surfacewaters,
or herbal extracts, originally contain blue fluorescent compounds
that can interfere the detection of MU [11,12]. To differentiate
http://dx.doi.org/10.1016/j.chroma.2017.03.047
0021-9673/© 2017 Elsevier B.V. All rights reserved.
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native fluorescences from the fluorescence arising from estrogenic
activity by pYES, the application of another substrate than MUG is
greatly advantageous. Therefore, resorufin-b-d-galactopyranoside
(RGP) was introduced as substrate, delivering orange fluorescing
resorufin and allowing the detection of EAC without interfering
signals due to blue or red fluorescing compounds in a sample. To
receive optimal conditions for the pYES test an adjustment of the
pH of the HPTLC plate was required. After the development of the
modified pYES, the system was tested by determining E2 and EE2
in spiked water samples. The applicability and precision of the
method was additionally demonstrated by studying waste water
samples. Since hormones are conjugated in the human body for
excretion [13], the waste water samples were also incubated with
b-glucuronidase and compared with untreated samples.
2. Materials and methods
2.1. Chemicals and materials
Yeast nitrogen base without amino acids (YNB) for culture
media was purchased from Sigma-Aldrich (Steinheim, Germany),
YNB for agar plates, agar, adenine, and casamino acids [14] were
from Becton Dickinson (Heidelberg, Germany). l-lysine (≥98%),
magnesium sulfate heptahydrate (puriss. p.a.), sodium sulfate
(anhydrous, >99%), n-hexane (for pesticide residue analysis) and
ethyl acetate (for pesticide residue analysis) were from Fluka-
Sigma-Aldrich (Steinheim, Germany). Ethanol (≥99.8%), methanol
(≥99.9%), t-butyl methyl ether (TBME, ≥99.8%), b-galactosidase
(from Aspergillus oryzae), b-glucuronidase (type H-2 from Helix
pomatia), 17b-estradiol (E2, ≥98%), 17a-ethinylestradiol (EE2,
≥98%), estrone (E1, ≥99%), and estriol (E3, ≥97%) were purchased
from Sigma-Aldrich. The following substances and materials were
from Merck (Darmstadt, Germany): l-histidine (≥99%), copper(II)
sulfate pentahydrate (p.a.), potassium chloride (>99%), disodium
hydrogen phosphate (p.a.), sodium acetate (anhydrous for anal-
ysis), potassium dihydrogen phosphate (p.a.), hydrochloric acid
(37%), sodium hydroxide solution (20%) and HPTLC glass plates sil-
ica gel 60 RP–18W (200mm×100mm, layer thickness 200mm).
D-Glucose (anhydrous) and sodiumhydrogen carbonatewere from
BDH Prolabo Chemicals (VWR, Bruchsal, Germany). Resorufin-b-
d-galactopyranoside (RGP) and b-estradiol-17-(b-d-glucuronide)
sodium salt were obtained from Santa Cruz biotechnology (Dallas,
USA). Dimethyl sulfoxide (DMSO, 99.98%) was from Fisher Scien-
tific (Schwerte, Germany), and sodium chloride (≥99%), acetone
(≥99.8%) and acetic acid (100%) were from Carl Roth (Karlsruhe,
Germany). Ultrapure water was produced by a Synergy System
(Millipore, Schwalbach, Germany). The used recombinant yeast
strain was Saccharomyces cerevisiae BJ3505 (protease deficient,
MATa, PEP4:HIS3, prb1-11.6R, HIS3-1200, lys2-801, trp1-1101,
ura3-52gal2can1) and was generated by McDonnell et al. [15,16].
The yeasts were stored in a cryo-vial at −70 ◦C. Orange filter glass
O 580 was from HEBO (Aalen, Germany) and was cut to shape as
optical filter for the TLC Scanner 4 (CAMAG,Muttenz, Switzerland).
The pH values of the HPTLC plates were measured by a pH meter
EL20/EL2 fromMettler Toledo (Columbus, USA)with a surface elec-
trode SenTix Sur fromWTW (Weilheim, Germany) using automatic
endpoint format. HPTLC plate incubationswere performed in a box
with approximately 100% relative humidity.
2.2. Stock and standard solutions
Standard stock solutions of E2 and EE2 were prepared in
ethanol (1mg/L). Standard solutions for calibration were obtained
by diluting the stock solutions with ethanol to concentrations of
1, 10 and 100 mg/L. Solutions of E1 (200mg/L) and E3 (500mg/L)
were prepared in ethanol. A stock solution of b-estradiol-17-(b-
d-glucuronide) was prepared in DMSO (60mg/L) and was diluted
with ultrapure water to a concentration of 20ng/L. Stock solutions
were stored at −20 ◦C.
2.3. Media and agars
Growthmedium for overnight cultures was composed of 6.8 g/L
YNB, 1 g/L glucose, 170mg/L L-lysine and 100mg/L L-histidine. The
solution of YNB plus amino acids and the solution of glucose were
sterilized separately by steam (120 ◦C, 20min) and were mixed
after autoclaving. Test medium for yeast incubations moreover
contained 112mM CuSO4. Plate agar consisted of YNB (6.7 g/L),
casamino acids (10g/L), adenine (50mg/L) and agar (20g/L).
2.4. Strain maintenance and cultivation of yeast cells for the pYES
(test culture)
To obtain isolated colonies of yeast cells, the cell mass of a cryo-
vial (stored at −70 ◦C) was streaked in a three-phase streaking
pattern on an agar plate that was incubated at 30 ◦C for at least 48h
followed by storage at 2–8 ◦C for a maximum of 2 months. About
50mL of growth mediumwere placed into a 250-mL shaking flask,
inoculated with a single colony from the agar plate and incubated
at 30 ◦C overnight with constant shaking at 150 rpm (incubating
mini shaker, orbit 3 mm, VWR, Darmstadt, Germany). An aliquot
(2mL) of an overnight culture was transferred into 50mL of fresh
growth medium and cultured overnight (30 ◦C, 150 rpm) to get a
fresh culture for the next day (repeatable for five days). The number
of cells was measured with a TC20 automated cell counter (Bio-
Rad Laboratories, Munich, Germany). For pYES, a cell number of
6–8×107 cells/mL was needed. For this purpose, the required vol-
ume of overnight cultures was centrifuged (2576g, Biofuge primo
R, Heraeus, Hanau, Germany) for 5min at room temperature, the
supernatant was discarded and the remaining cell pellets were re-
suspended in 40mL of test medium (for glass dipping chamber for
10 cm×10 cmplates, biostep, Burckardtsdorf, Germany). Flasks for
cultivation were without baffles and were sterilized by steam at
120 ◦C for 20min before use.
2.5. Substrate solution
A stock solution of resorufin-b-d-galactopyranoside (RGP) with
a concentration of 20 mg/mL in DMSO was prepared and stored at
−20 ◦C. The substratedipping solution (0.1mg/mL)wasobtainedby
diluting the stock solution (200mL) with phosphate buffer (40mL)
consisting of KH2PO4 (40.8 g/L), Na2HPO4 (42.6 g/L), MgSO4·7H2O
(1.2 g/L) and KCl (3.7 g/L), adjusted to pH 7 with sodium hydroxide
solution (20%).
2.6. Planar yeast estrogen screen (pYES)—general procedure
HPTLC glass plates silica gel 60 RP–18W were prewashed with
acetone/water (9/1, v/v) and dried for 30min at 120 ◦C on the TLC
PlateHeater III (CAMAG). The cooled downplateswere dippedwith
the chromatogram immersion device (CAMAG, time 3 s, speed 3)
into a solution of sodium hydrogen carbonate (25g/L) adjusted to a
pH of 6.4with hydrochloric acid (37%) and dried in a cold airstream
for 5min. Sample applications were performed with an Automatic
TLC Sampler 4 (ATS 4, CAMAG) at 10mm from both the lower edge
and the left side. The rinsing solvent was ethanol. Extracts of water
samples (50mL) were applied onto 10 cm×10 cm HPTLC plates as
5mm×10mm areas, and different volumes of the standard solu-
tions as 5mm bands, resulting in 3, 5, 10, 50, 100, and 200 pg E2
and EE2 per band (track distance set to automatic). The plate was
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first developed with methanol up to 15mm to focus the applica-
tion areas and dried for 2min in a cold airstream. The second plate
development was performed with n-hexane/toluene/ethyl acetate
(4/1.5/2, v/v/v) [12] up to amigration distance of 70mm. The devel-
opments were carried out in a twin-trough chamber (10 cm x 10
cm, CAMAG). Subsequently, the plate was dried for two minutes
in a cold airstream, immersed with the chromatogram immersion
device (time 3 s, speed 3) into a test culture adjusted to 6-8×107
cells/mL and left in the vertical position for 30–60 s for uniformdis-
tribution of yeast cells. The plate was incubated in a box (relative
humidity, RH∼100%, 30 ◦C) for 4 h. After drying in a cold airstream
for five minutes, the plate was dipped into RGP substrate solution
(0.1 mg/mL, time 3 s, speed 3) and incubated at 37 ◦C in a box with
approximately 100% RH for 30 min. Drying, dipping and incuba-
tionwas repeated two times. Plate imageswere captured under UV
254nm and UV 366nm (TLC Visualizer, CAMAG), and the plate was
scanned in fluorescence mode at 550/ >580nm using the tungsten
lamp (TLC Scanner 4, CAMAG). HPTLC instruments were controlled
by the software winCATS, version 1.4.6 (CAMAG).
2.7. Optimization of substrate incubation
An aqueous solution of b-galactosidase (1 mg/mL) was applied
(1mL, 5mm bands) onto 10 tracks (distance 20mm) of six HPTLC
plates (20 cm×10 cm). The plates were cut into 2 cm×10 cm sec-
tions (smartcut plate cutter, CAMAG). Half of the plate stripes were
immersed into a substrate solution of RGP (0.1 mg/mL, time 3
s, speed 3) and incubated at 37 ◦C (without box) for 10, 20, 30,
40, 50, 60, 70, 80, 90 and 100min (n=3). The other plate stripes
were dipped in substrate solutions of various concentrations of RGP
(0.01, 0.02, 0.04, 0.06, 0.1, 0.15. 0.2, 0.25, 0.35 and 0.5mg/mL) and
incubated for 50min at 37 ◦C (without box; n=3).
2.8. Optimization of yeast incubation
A standard solution of E2 (1mg/L) was applied (10mL) onto
10 tracks (5mm bands, distance 20mm) of eight HPTLC plates
(20 cm×10 cm). The plates were cut into 2 cm×10 cm stripes,
whichwere dipped into yeast cell suspensions of different cell den-
sity (time3s, speed3).After incubationat30 ◦C inabox (RH∼100%)
for 3h, the stripes were dried in a cold airstream for five min-
utes. The plate stripes were dipped into a RGP substrate solution
(0.1mg/mL, time 3 s, speed 3) and incubated (30min, 37 ◦C, with-
out box). Drying, dipping and incubation were repeated two times.
In addition, 10pg of E2 (10 mL of a 1 mg/L solution, 5mm bands,
distance 20mm) were applied onto 10 tracks of two HPTLC plates
(20 cm×10 cm). After cutting the plates into 2 cm×10 cm sections,
the stripes were dipped in a test culture with a cell density of
6–8×107 cells/mL and incubated at 30 ◦C in a box (RH∼100%) for
2, 3, 4, 5, and 6h (n=4). Thereafter, the plate stripes were dried for
5min in a cold airstream, and substrate incubation was performed
as described above.
2.9. Limits of detection and quantitation (LOD/LOQ)
For the determination of LOD and LOQ, 1–10mL of a 1mg/L
standard solution of E2 and EE2 were applied onto 10 tracks
of 10 cm×10 cm HPTLC plates as 5mm bands. The plates were
developed in a twin-trough chamber with n-hexane/toluene/ethyl
acetate (4/1.5/2, v/v/v) [12] up to a migration distance of 70 mm.
Yeast incubation, substrate incubation, and plate evaluation were
performed as described above (2.6 pYES general procedure).
2.10. Sample extraction and deconjugation of EAC in waste water
The extraction and the followingpYESwere testedwith aqueous
solutionsofE2andEE2at fourdifferent levelsof2, 6, 14, and20ng/L.
Aliquots of the spiked samples (30 mL) were transferred to 40-mL
centrifuge tubes containing 6g of sodium chloride. TBME (5mL)
was added, and the tubes were closed and placed on an orbital
shaker (KS125 basic from IKA, Staufen, Germany; orbit 4 mm) for
30min at 800 rpm. The organic phase was separated in a MIXXOR
liquid–liquid extraction system(LidexTechnologies, Bedford,USA),
evaporated by a stream of nitrogen, and the residue was dissolved
in 200mL of ethanol. In addition, ultrapure water was extracted in
the sameway to obtain a blank extract. The extracts were stored at
−20 ◦C until analysis.
Wastewater sampleswere taken froma localwastewater treat-
ment plant (Treatment Plant for Education and Research, in the
westof the city Stuttgart,Germany). Theplant treats thedailywaste
water of about 10,000 inhabitants corresponding to about 2000m3
of sewage daily. Influent and effluent samples were taken in the
morning (April 2016), andwere frozenuntil analysis to prevent oxi-
dation of E2 [13]. After thawing, the sewage water samples were
extracted in the same way as the spiked samples. However, the
obtained extract (TBME) volume was determined with a measur-
ing cylinderwithgraduationdivisionsof 0.1mL, and theapplication
volumes (pYES) were adapted with regard to the obtained TBME
volume of a blank extract. In case of an occurring emulsion layer
after shaking (observed for influent samples), the emulsion and the
TBME phase were separated from the aqueous phase by removing
the lower water phase with a pipette. Sodium sulfate (anhydrous)
was added until the emulsion was broken, and the received TBME
volume was determined. TBME was removed by a stream of nitro-
gen, and the residuewasdissolved in200mLof ethanol. Theextracts
were stored at −20 ◦C until analysis. Additionally, the waste water
samples were treated with a solution of b-glucuronidase (type H-
2 from Helix pomatia, ≥85,000 units/mL, with additional sulfatase
activity≤7500units/mL) to hydrolyze possibly present conjugated
EAC. Therefore, 30mLof the sewage samplesweremixedwith 3mL
of 1M sodium acetate buffer (pH 5.5) and subsequently with 10 mL
of the 10-fold diluted enzyme solution. Incubation was performed
at 37 ◦C for 16 h. After cooling down, the extraction was performed
as described for the untreated waste water samples. Additionally,
the efficiency of the enzyme solution was tested with a water sam-
ple spiked with b-estradiol-17-(b-d-glucuronide) (20 ng/L), and
‘hydrolyzed blanks’ were also extracted, when the acetate buffer
and the enzyme solution were added to ultrapure water, followed
by incubation.
3. Results and discussion
3.1. pH adjustment of HPTLC plates
The advantageous application of HPTLC glass plates silica gel 60
RP–18W to obtain sharp-bounded zones despite the humid condi-
tionsduring thepYESassayhas alreadybeendemonstrated,when it
also was shown that the acidic plate material requires a pH adjust-
ment to get a detectable signal of MU [10]. The pH adjustment was
achieved with a substrate solution of MUG in citric buffer with a
pH of 12 and an additional stop solution of pH 12 to terminate
the substrate reaction [10]. For the planar YES in the present work,
the recombinant yeast strain Saccharomyces cerevisiae generated
by McDonnell et al. [15,16] was used. An expression vector for the
human estrogen receptor (hER) was constructed and inserted in
the yeast [15]. Also, a reporter plasmid was created which con-
sists of the yeast iso1-cytochrome c proximal promoter elements
which are fused to the structural gene for b-galactosidase from
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Table  1
Mean  pH values of HPTLC plates RP-18 W measured with a surface electrode (n = 6);
sodium hydrogen carbonate solution: 25 g/L, pH 6.4; incubation with test culture 3
h,  30 ◦C, closed box, RH ∼ 100%; substrate incubation: substrate RGP in phosphate
buffer  (0.6 M,  pH 7), 37 ◦C, 30  min.
Treatment mean pH
value  ± SDa
Without pretreatment 4.7 ± 0.3
After treatment with sodium hydrogen carbonate solution 6.5 ± 0.3
After incubation with test culture 5.8 ± 0.2
After first substrate incubation 6.5 ± 0.1
After second substrate incubation 6.6 ± 0.1
After third substrate incubation 6.7 ± 0.2
a standard deviation.
Escherichia coli (lacZ-CYC fusion) [15,17,18]. By binding a ligand,
the transcription of the lacZ reporter gene is induced and thus the
production of b-galactosidase [16]. With regard to the integrated
reporter plasmid, the optimal pH range for the b-galactosidase
had to be considered. The maximum activity of b-galactosidase
from Escherichia coli with o-nitrophenyl-b-d-galactoside as sub-
strate was obtained at  a pH 7.2-7.3, and the enzyme was stable in a
pH range of 6–8 [19]. Therefore, the pH of the HPTLC plate should
be above 6 to ensure the optimal cleavage of the substrate by the
enzyme. The pH span for optimal growth and metabolism of yeasts
was reported between 4.5 and 6.5 [20], wherefore such a pH range
should be achieved on the plate during incubation with the test
culture. On average, the measured pH of the HPTLC RP–18 W plate
was below 5 (Table 1). This would be a fair pH for yeast incuba-
tion, but far away from the ideal pH for b-galactosidase activity.
As resorufin-b-d-galactopyranoside (RGP) is not stable at a pH of
12 (the solution showed a dark coloration within a few minutes),
another way had to be  found to adjust the pH of the plate layer to the
requirements of both yeast cells and b-galactosidase. Thus, the pH
of the prewashed plates was adjusted to >6 by dipping them into
a solution of sodium hydrogen carbonate (Table 1). During yeast
incubation, the pH decreased to just below 6 (Table 1). Hence it  was
possible to use a substrate solution buffered to pH 7, like reported
in literature [7,8], to raise the pH after yeast incubation above 6,
but the buffer concentration was chosen to 0.6 M to really ensure
the pH increase for the enzyme reaction. Thus, HPTLC plates were
dipped into substrate solution (0.1 mg/mL  RGP in 0.6 M buffer) and
incubated at 37 ◦C for 30 min. After the incubation, the plates were
dried, dipped again into substrate solution and incubated again.
This step was repeated a third time. After the three-fold substrate
incubation, the measured pH on the plate was between 6.5 and 7
(Table 1). Triple immersion not only increased the pH value and
thus the signal, but also resulted in more homogenous distribution
of the substrate on the plate. Enzymatic hydrolysis of the substrate
RGP releases resorufin, which is fluorescent only in its anionic form,
but has a relatively low pKa of 5.8 [21]. Consequently, 80–90% of
the resorufin should be present in the deprotonated form at  the
plate pH determined after triple substrate incubation. Attempts
have been made to raise the pH after the substrate incubation even
further to obtain more molecules in the anionic form. Therefore,
plates were dipped in different carbonate buffers (0.1 M, pH 10 and
11; 0.3 M,  pH 10; 0.5 M,  pH 9 and 10; 1 M,  pH 9 and 10), which, how-
ever, did not improve signal intensities or even resulted in damage
of the plate layer (blisters, flaking off).
3.2. Substrate incubation
To  determine the  optimal parameters for the substrate reac-
tion, substrate solutions of varying concentrations and different
periods of substrate incubation were examined, when all incuba-
tions were performed at  37 ◦C  according to the temperature given in
literature [7,8,10]. Therefore, the same amount of b-galactosidase
was multiply applied on different plate stripes. For the determi-
nation of the optimal incubation time, a substrate solution of 0.1
mg/mL  RGP was used based on data reported in literature (RGP used
in a flow cytometric assay [22]). The maximum signal was obtained
at an incubation time of 50 min  (Fig. S1). However, since already
96% of the maximum signal were reached after 30 min  of incuba-
tion, the incubation time for the substrate reaction was defined
to 30 min. When plotting the measured signals against the asso-
ciated concentrations of RGP, a curve was  observed that showed
a high slope at the beginning and started to flatten at  concentra-
tions above 0.06 mg/mL  (Fig. S2). At 0.2 mg/mL  RGP, about 90%, and
at  0.1 mg/mL, about 80% of the signal of the highest examined con-
centration of 0.5 mg/mL  were reached. However, the formation of a
whitish precipitation was observed in solutions of 0.2 mg/mL RGP
or higher concentrations after storage at  −20 ◦C that did not re-
solubilize and that remained on the  plate afterwards. Therefore,
the optimal concentration of the  substrate solution was defined to
0.1 mg/mL  RGP.
3.3.  Cell density and incubation time with yeast cells
To  find out the optimal cell density for pYES, E2  (10  pg) was mul-
tiply applied on different plate stripes, which were dipped into test
cultures of cell densities up to 5.5 x 107 cells/mL and were incubated
for 3 h at 30 ◦C (RH ∼ 100%). An incubation time of 3 h was chosen
based on literature [10]. At cell densities above 1.0 × 107 cells/mL,
at first it seemed that saturation was  reached (Fig. S3). At cell den-
sities higher than 2.8 x 107 cells/mL, however, a further increase of
the fluorescence signal was observed. Therefore, test cultures with
cell densities up to 1.5 × 108 cells/mL were prepared. The  experi-
ment was repeated five times on five different days with both a new
test culture and HPTLC plate (each plate pretreated with a freshly
prepared solution of sodium hydrogen carbonate). The resulting
fluorescence signal increased with the increasing number of cells,
passing a maximum between about 6 × 107 and 1 × 108 cells/mL
(Fig. S4). Therefore, a span of about 6 × 107 to 8 × 107 cells/mL was
chosen as optimal cell densities for further experiments.
To determine the optimal incubation time with yeasts, again 10
pg of E2  were applied on plate stripes, which were dipped into a cell
suspension of 6–8 × 107 cells/mL and incubated for different times
from 2 to 6 h (30 ◦C, RH ∼ 100%). The fluorescence signal of resorufin
increased strongly during the first 3 h until the curve flattened at an
incubation time of 4 h (Fig. S5), when also the standard deviations
became rather low. Thus, it was assumed that a stable expression of
b-galactosidase was reached and the optimal incubation time with
yeast cells was defined to 4 h.
3.4. pYES
The final conditions for the pYES, sketched in Fig. 1, were chosen
based on the results of the executed experiments. The HPTLC plates
were pretreated, extracts and standard solutions were applied and
the analytes were separated by chromatography. Cell density for
yeast incubation was adjusted to 6–8 x  107 cells/mL. The plates
were left in a vertical position after immersion in test culture
for 30–60 s  to obtain a uniform distribution of yeast cells on the
plate. Yeast incubation was performed in a closed box at approxi-
mately 100% RH at 30 ◦C  for 4 h. After incubation with yeast cells,
the substrate incubation was  performed (0.1 mg/mL RGP in 0.6 M
phosphate buffer, pH 7). For pH enhancement and thus the signal
intensity, and to obtain an even background, the substrate incuba-
tion was  executed in a closed box  (RH ∼ 100%) three times at 37 ◦C
for 30 min. Orange fluorescence of the  released resorufin was docu-
mented under UV 254 nm and 366 nm and the plates were scanned
at 550 nm with an optical filter (>580 nm)  in fluorescence mode.
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Fig. 1.  Schema of the pYES procedure.
Since resorufin is not only a fluorescing but also a  chromogenic
substrate, the signals were also visible with the  naked eye as pink
zones on a yellow background, which additionally can be detected
in absorption mode at 572 nm,  but with a  loss of sensitivity.
3.5. Limits of detection and quantitation and working range
The  limit of detection (LOD) and the limit of quantitation (LOQ)
were determined by means of the signal-noise-ratio (S/N). LOD is
defined as S/N ≥ 3 and LOQ as S/N ≥ 10. On average, the LOD for
E2 and EE2 was determined to 3 ± 0.5 and 4 ±  0.7 pg/zone, respec-
tively; the LOQ was 5 ± 1.8 and 8 ± 1.0 pg/zone, respectively (n =  7).
The suitable range for the quantitation for E2 and EE2 was cho-
sen on the basis of the determined LOD and the correlation of
calibration curves of several measurements. A good correlation was
obtained in a range of  LOD-200 pg per zone for both E2 and EE2 (Fig.
S6). The coefficients of determination (R2) were between 0.9538
and 0.9911 for E2 and between 0.9927 and 0.9992 for EE2  (n =  9).
Especially at low amounts of E2 and EE2, the relative standard devi-
ations (% RSD) of the obtained signal were relatively high, which is
due to the fact that the tests outcome is  dependent on i) the daily
condition of  the yeast cells, ii) the number of cells  and iii) the back-
ground expression of b-galactosidase. On average, the RSD of the
individual measuring points of the  calibration graph (Fig. S6) was
25% RSD for both E2 and EE2.
3.6. Sample extraction and recovery rates
To show the applicability of the utilized liquid–liquid extrac-
tion (LLE) over the previously defined working range, recoveries
of E2 and EE2  at four different levels from aqueous solutions were
determined. Therefore, ultrapure water was spiked with E2 and
EE2 in concentrations of about 2, 6, 14, and 20 ng/L, and aliquots of
30 mL were extracted with TBME. After evaporation of  the TBME,
the residue was  dissolved in  200  mL of  ethanol, resulting in  a 150-
fold enrichment. Application of  50 mL  of the extracts onto an HPTLC
plate resulted in amounts of  about 15,  45, 105, and 150 pg/zone for
E2 and EE2, which were well in the calibration range. The obtained
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Fig. 2. (A) pYES of a blank sample extract (track 1), spiked and extracted water samples (tracks 2–5: extracts 2ng/L, 6ng/L, 14ng/L, 20ng/L), and calibration standards of E2
and EE2 (tracks 6–11: 3, 5, 10, 50, 100, 200pg/zone) on HPTLC RP–18Wplates under UV 254nm (a) and under white light illumination (b); (B) corresponding 3D densitogram
of the fluorescence scan at 550/ >580nm; (C) calibration curve exemplarily for E2 at 550/ >580nm, analyzed samples are displayed as a triangle.
Table 2
Recoveries for E2 and EE2 from spiked water samples (n =6).
Substance Spiked level [ng/L] Determined concentration [ng/L] Recovery [%] RSD [%]
E2 1.98 1.80 91 15
5.95 6.45 108 25
13.89 14.26 103 17
19.84 19.55 99 17
EE2 1.99 2.09 105 16
5.98 6.21 104 20
13.94 14.83 106 15
19.92 22.50 113 17
46
D. Schick, W. Schwack / J. Chromatogr. A 1497 (2017) 155–163 161
Fig. 3. (A) Tracks of a blank sample extract, extracted waste water samples (effluent and influent), and a reference track with E3 5ng/zone, E2 100pg/zone, EE2 100pg/zone
and E1 1ng/zone after chromatography under UV 366nm (a), after yeast incubation under UV 366nm (b), and after pYES under UV 254nm illumination with orange zones
showing estrogenic activity (c); (B) 3D densitogram of a fluorescence scan at 550/ >580nm of the tracks c after pYES. (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article.)
Table 3
Results of pYES for original and hydrolyzed effluent and influent waste water samples; observed increase of the peak areas after hydrolysis written in bold.
substance hRF original
effluent
hydrolyzed
effluent
%peak area
hydrolyzed/original
effluent
original
influent
hydrolyzed
influent
%peak area
hydrolyzed/original
influent (n =4)
E3 9 – – – +a +a 111±12% RSD
unknown2 23 – – – + + 195±7% RSD
E2 34 – – – 16.9ng/L
(±11% RSD, n=4)
17.0ng/L
(±18% RSD, n=4)
99±7% RSD
EE2 46 – – – – – –
E1 51 – – – +a +a 126±9% RSD
unknown1 56 + + 92±9% RSD – – –
a not quantified.
Fig. 4. Plate images after pYES of extracts of original and hydrolyzed waste water samples under UV 366nm illumination after chromatography (A) and under UV 254nm
illumination after pYES (B); 1 blank (extracted ultrapure water), 2 hydrolyzed blank, 3 original effluent, 4 hydrolyzed effluent, 5 original influent, 6 hydrolyzed influent, 7–12
calibration standards: 3, 5, 10, 50, 100, 200pg/zone of E2 and EE2, respectively.
results are exemplarily shown in Fig. 2. The recovery experiments
were performed on six days and revealed mean recoveries of 100%
and 107% for E2 and EE2, respectively (Table 2). The high recoveries
demonstrate that the developed screening (extraction plus pYES)
showed a good accuracy. Relative standard deviations up to 25%
are appropriate, considering that the method works with microor-
ganisms in a low nanogram range.With a sample volume of 30mL,
a concentration factor of 150 and an application volume of 50mL,
the developed method is suited for the detection of E2 and EE2
in samples down to 0.4ng/L for E2 and 0.6ng/L for EE2. Hence, the
developedpYESmeets the requirements of themaximal acceptable
method detection limit of 0.4 ng/L for E2 of the EU watch list [1].
However, to meet the maximal acceptable method detection limit
of 0.035ng/L for EE2, the extraction of higher sample volumes is
required.
3.7. Analysis of waste water samples
Finally, the analytical procedure was tested with real samples,
influent and effluent waste water of a local waste water treat-
ment plant. Under UV 366nm illumination, especially the influent
extracts showed several zoneswith blue and red fluorescence after
chromatography and still after the yeast incubation (Fig. 3A). How-
ever, after substrate incubation, some of these zones were weaker
or not visible anymore, whereas zones with estrogenic activity
became visible by an orange fluorescence, and no interferences
were detected on tracks of blank extracts. Due to the use of the sub-
strateRGPandappropriate settings fordensitometry, the scansonly
showed peaks of zones with an orange fluorescence, thus zones
of substances with estrogenic activity, whereas zones with native
blue and red fluorescence were suppressed (Fig. 3B). The results of
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the pYES of the effluent and influent extracts are summarized in
Table 3. In the influent waste water, E2 was clearly be quantified to
about17ng/L, EE2wasnotdetectable, butE3andE1couldclearlybe
identified (calibrationwasnot performed),while the effluentwaste
water was free of them. Besides, two unknown EAC were found in
the influent and the effluent (unknown1 hRF 56, unknown2 hRF 23).
In a report of the Global Water Research Coalition relative stan-
dard deviations of several methods for the determination of EAC
in spiked and environmental water samples were presented [23].
The results for the RSD of different bioassays (inter alia two YES
assays and an E-Screen) and chromatographic methods were com-
pared. Both YES assays showed about 40% RSD, other bioassays
showed at least 25% RSD or even higher RSD. Compared with the
RSD presented in the mentioned report, the pYES developed in the
present study showed a good precision of 11% RSD (n=4) for the
determination of E2 in the influent samples.
Since hormones are excreted as conjugates (sulfates, glu-
curonides) [13], thewastewater sampleswere additionally treated
with a suitable enzyme to hydrolyze possibly present EAC con-
jugates. The efficiency of the used glucuronidase was first tested
by treating a pure water sample spiked with b-estradiol-17-(b-d-
glucuronide) (20ng/L), and itwasobserved that10mLof the10-fold
diluted enzyme solution were sufficient to hydrolyze the spiked
glucuronide (data not shown). Therefore, 30mL of the waste water
samples were treated with the enzyme followed by extraction in
the same way as the original samples. Additionally, sample blanks
(influent and effluent) without adding enzyme solution were incu-
bated like the enzyme assays, to ensure that the conditions do not
cause changes to the sample itself (due to increased temperature
and storage time [13]); but the extracts of the sample blanks did
not show any differences as compared to the original untreated
samples (data not shown). Besides, the enzyme solutionwas added
to ultrapure water and incubated overnight, which verified that
the enzyme did not yield false positive signals. After pYES (plate
images exemplarily shown in Fig. 4), the fluorescence signal of the
unknownEACat hRF 23 (unknown2) in the hydrolyzed influentwas
nearly twice as compared to the original influent (Table 3). A slight
increase of the E1 signal was also observed after enzyme treat-
ment. Concerning the other EAC, however, no essential differences
between original and hydrolyzed samples were observed.
4. Conclusions
Resorufin-b-d-galactopyranosidewas shown tobea rather suit-
able substrate, releasing orange fluorescing resorufin and allowing
the pYES of environmental samples to be performedwithout inter-
ferences by natively blue or red fluorescent contaminants. The
modified pYES showed a high selectivity for the targeted analytes
since clearly resulting signals only were based on the yeast activity
and the produced enzyme, respectively, due to present estrogen
active compounds. Due to the minimized sample preparation (LLE,
concentration factor of 150) no further steps of purification such as
a solid-phase extractionwere required, when estrogen active com-
pounds in water samples were extracted with high recoveries and
could be quantified down to a low ng/L level. Besides, the presence
of conjugated estrogen active compounds in waste water influent
samples was proven.
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Supplementary data 
Figure S1. Fluorescence signal (550/>580 nm) of released resorufin depending on the time of 
substrate (0.1 mg RGP/mL) incubation after application of 1 µg β-galactosidase (n = 3).  
Figure S2. Fluorescence signal (550/>580 nm) of released resorufin depending on the substrate 
concentration (n = 3, n = 1 for 0.01 and 0.02 mg RGP/mL) after application of 1 µg β-galactosidase. 
Figure S3. Fluorescence signal (550/>580 nm) of released resorufin after application of 10 pg E2, 
incubation (3 h) with yeast cells at different densities (up to 5.5 x 107 cells/mL), dipping into substrate 
(0.1 mg RGP/mL) and incubation (37°C for 30 min).  
Figure S4. Fluorescence signal (550/>580 nm) of released resorufin after application of 10 pg E2, 
incubation (3 h) with yeast cells at different densities (up to 1.5 x 108 cells/mL), dipping into substrate 
(0.1 mg RGP/mL) and incubation (37°C for 30 min).  
Figure S5. Relative fluorescence signal (550/>580 nm) of released resorufin after application of 10 pg 
E2 depending on incubation time with yeast cells (n = 4); after 6 h set to 100%. 
Figure S6. Calibration graphs for E2 and EE2; fluorescence signal at 550/>580 nm (n = 9). 
 
51



Figure S1. Fluorescence signal (550/>580 nm) of released resorufin depending on the time of 
substrate (0.1 mg RGP/mL) incubation after application of 1 µg β-galactosidase (n = 3).  
Figure S2. Fluorescence signal (550/>580 nm) of released resorufin depending on the substrate 
concentration (n = 3, n = 1 for 0.01 and 0.02 mg RGP/mL) after application of 1 µg β-galactosidase. 
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Figure S3. Fluorescence signal (550/>580 nm) of released resorufin after application of 10 pg E2, 
incubation (3 h) with yeast cells at different densities (up to 5.5 x 107 cells/mL), dipping into substrate 
(0.1 mg RGP/mL) and incubation (37°C for 30 min).  
Figure S4. Fluorescence signal (550/>580 nm) of released resorufin after application of 10 pg E2, 
incubation (3 h) with yeast cells at different densities (up to 1.5 x 108 cells/mL), dipping into substrate 
(0.1 mg RGP/mL) and incubation (37°C for 30 min).  
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Figure S5. Relative fluorescence signal (550/>580 nm) of released resorufin after application of 10 pg 
E2 depending on incubation time with yeast cells (n = 4); after 6 h set to 100%. 
Figure S6. Calibration graphs for E2 and EE2; fluorescence signal at 550/>580 nm (n = 9). 
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a b s t r a c t
Receptor assays like the yeast estrogen screen (YES) performed in microtiter plates normally provide
dose-response curves with a sigmoidal shape in semi-log plots. Such sigmoidal plots can be linearized
by the logit function resulting in logit-log plots, as mainly known for the evaluation of enzyme-linked
immunosorbent assays and radioimmunoassays. Since the planar yeast estrogen screen (pYES) repre-
sents the transfer of the receptor assay YES to high-performance thin-layer chromatography (HPTLC), it
was assumed to obtain sigmoidal shaped dose-response curves from themeasured signals, which subse-
quently could be used to generate logit-log plots. However, it was observed that typical sigmoidal curves
were not obtained, when peak areas were plotted against the applied amount on a logarithmic scale
(log amount). Therefore, peak heights were examined in the present study, which revealed proper dose-
response curves when plotted against the log amount. The presence of sigmoidal dose-response curves
from HPTLC-pYES made it possible to transform the signals into logits and, therefore, to create logit-log
plots with linear correlations. The logit-log plots for the estrogen active compounds (EAC) 17b-estradiol
(E2) and 17a-ethinylestradiol (EE2) provided aworking range up to 500pg/zone. Applying logit-log plots,
mean recovery rates for E2 and EE2 from spiked water samples (2–20ng/L) were determined to 90% and
108%, respectively, with ≤24% RSD. Moreover, the linear graphs allowed an easy determination of the
half maximal effect dose (ED50) of EAC, since the intersection of the graph with the abscissa represents
the ED50. Additionally, with the knowledge of the ED50 values, the estrogenic potential of EAC in terms
of estradiol equivalent factors (EEF) could be determined, resulting in 0.64 for EE2.
© 2017 Elsevier B.V. All rights reserved.
1. Introduction
The yeast estrogen screen (YES), introduced by Routledge and
Sumpter, is a receptor assay performed in microtiter plates to
determine estrogen active compounds (EAC) in terms of effect-
directed analysis. For the assay, genetically modified yeast cells
containing thehumanestrogen receptor (hER) and the lacZ reporter
gene encoding for b-galactosidase were employed [1]. The hER is
activated by binding EAC present in a sample, and subsequently
the activated hER binds to an estrogen-responsive element caus-
ing transcriptions leading to the expression of the reporter gene
that results in the production of the enzyme [1]. By enzymatic
cleavage, the substrate chlorophenol red b-d-galactopyranoside
releases chlorophenol red to be determined by absorbance as indi-
rect signal of theestrogenic activityof EAC [1]. Such ligand-bindings
are equilibrium processes that usually show saturation, observ-
able as dose-response curves with a typical sigmoidal shape in
semi-log plots. By plotting the YES absorbance signals against the
∗ Corresponding author.
E-mail address:wolfgang.schwack@uni-hohenheim.de (W. Schwack).
respective concentrations on a logarithmic scale, sigmoidal dose-
response curveswereobtained, as exemplarily shownbyRoutledge
and Sumpter or van den Belt et al. [1,2].
The transfer of the YES assay to high-performance thin-layer
chromatography (HPTLC-planar yeast estrogen screen, HPTLC-
pYES) was already shown and provides the great chance to
chromatographically separate individual EAC before pYES is per-
formed directly on the HPTLC plate [3–6]. However, when
HPTLC-pYES signals expressed as peak areas were plotted against
the respectively applied amounts of EAC on a logarithmic scale,
typical sigmoidal curves generally were not obtained. Schönborn
and Grimmer reported increasing zones and signal intensities,
when increasing amounts of EAC were applied, but showed
the dose-response relationship for 17b-estradiol (E2) and 17a-
ethinylestradiol (EE2) only in a range of 0.5–25pg/zone, resulting
in linear graphs [3]. The dose-response curve for EE2 in a range
of 0.3–100pg/zone was shown by Spira et al., when peak areas
were plotted against the applied amount on a log scale, but no real
sigmoidal curve was observable [4]. However, by applying a four
parametric logistic function curve-fitting model to the data, values
for the half maximal effect dose (ED50) were obtained [4]. Results
were given in half maximal response instead of half maximal effect
http://dx.doi.org/10.1016/j.chroma.2017.06.035
0021-9673/© 2017 Elsevier B.V. All rights reserved.
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concentrations (EC50),  thus as the ratio of the amounts applied [4].
First, Klingelhöfer and Morlock showed a  reliable and  profound
investigation of E2 equivalency results based on dose-response
curves (showing 4 repetitions each) for six different EAC in differ-
ent ranges using 4-methylumbelliferyl-b-d-galactopyranoside as
substrate [5], well-suited also for quantitation of  EAC in complex
samples [7,8].
The  presence of sigmoidal curves with upper and lower asymp-
totes provides the opportunity to generate logit-log plots as linear
calibration curves. The transformation of sigmoidal curves to lin-
ear graphs by applying the logit function is  mainly used for
radioimmunoassays [9–11], and is also known from enzyme-
linked immunosorbent assays [12], both performed in cuvettes
or microtiter plates. Alternatively, log-log plots or  four parameter
logistic-log functions were also used [13]. The aim of the present
study was to obtain proper dose-response curves from the signals
of a recently developed HPTLC-pYES with the substrate resorufin-
b-d-galactopyranoside (RGP) [6] and subsequently to apply the
logit-log method. The applied HPTLC-pYES utilized the recombi-
nant yeast strain Saccharomyces cerevisiae generated by McDonnell
et al. [14,15], which is  modified with a  DNA sequence of the hER and
the lacZ reporter gene that encodes for b-galactosidase. Enzymatic
cleavage of the suitable substrate RGP releasing resorufin indicates
estrogenic activity as orange fluorescent HPTLC zones [6]. Since
plotting peak areas of  the signals of a  fluorescence scan against
the amount per zone on  a log scale did  not  result in curves with a
sigmoidal shape, the peak height as signal of intensity was exam-
ined, which indeed showed saturation curves for both E2 and EE2.
Hence, it was possible to demonstrate the transfer of the logit-log
procedure to HPTLC-pYES, resulting in linear calibration graphs.
The applicability of logit-log plots as evaluation tool in HPTLC-
pYES was tested with water samples spiked with E2 and  EE2, and
the obtained results were compared to the results from the former
publication [6]. Moreover, the presence of sigmoidal dose-response
curves enabled the determination of values for the half maximal
effect dose (ED50), on the one hand as the point of inflection of the
curve from the sigmoidal curve itself, on the other hand simply
from the intersection of the linear graph of a  logit-log plot with the
abscissa. Thus, it was possible to determine ED50 values for E2 and
EE2, and, therefore, the estrogenic potential of EE2 in terms of the
estradiol equivalent factor (EEF).
2. Materials and methods
2.1.  Chemicals and materials
HPTLC  glass plates silica gel 60 RP–18 W (200 mm  ×  100 mm,
layer thickness 200 mm),  copper(II) sulfate pentahydrate (p.a.), dis-
odium hydrogen phosphate (p.a.), L-histidine (≥99%), hydrochloric
acid (37%), potassium chloride (>99%), potassium dihydrogen phos-
phate (p.a.) and sodium hydroxide solution (20%) were from Merck
(Darmstadt, Germany). The following substances for agar plates
were from Becton Dickinson (Heidelberg, Germany): yeast nitro-
gen base without amino acids (YNB), casamino acids [16], adenine
and agar. YNB for culture media, ethanol (≥99.8%), methanol
(≥99.9%), t-butyl methyl ether (TBME, ≥99.8%), 17b-estradiol
(E2, ≥98%) and 17a-ethinylestradiol (EE2, ≥98%) were purchased
from Sigma-Aldrich (Steinheim, Germany). Sodium hydrogen
carbonate and D-Glucose (anhydrous) were from BDH Prolabo
Chemicals (VWR, Bruchsal, Germany). Ethyl acetate (for pesti-
cide residue analysis), n-hexane (for pesticide residue analysis),
L-lysine (≥98%) and magnesium sulfate heptahydrate (puriss. p.a.)
were obtained from Fluka-Sigma-Aldrich (Steinheim, Germany).
The substrate resorufin-b-d-galactopyranoside (RGP) was  from
Santa Cruz biotechnology (Dallas, USA) and dimethyl sulfoxide
(DMSO,  99.98%) from Fisher Scientific (Schwerte, Germany). Ace-
tone (≥99.8%) and sodium chloride (≥99%) were from Carl Roth
(Karlsruhe, Germany). Ultrapure water was prepared using a Syn-
ergy System (Millipore, Schwalbach, Germany). For pYES, yeasts
of the strain Saccharomyces cerevisiae BJ3505 (protease deficient,
MATa, PEP4:HIS3, prb1-1 1.6R, HIS3-1200, lys2-801, trp1-1 101,
ura3-52gal2can1) were used. The yeast strain was  generated by
McDonnell et al. [14,15] and the yeasts were stored in a cryo-vial
at −70 ◦C.  As optical filter for the TLC Scanner 4 (CAMAG, Muttenz,
Switzerland), orange filter glass O 580 from HEBO (Aalen, Germany)
was cut to shape.
2.2.  Solutions, media and agars
Standard solutions of  E2 and EE2 in concentrations of 1 mg/L,
10 mg/L and 100 mg/L were prepared by respectively diluting the
stock solutions (1 mg/L). The solvent for standard solutions as
well as stock solutions was ethanol. Growth medium was  com-
posed as described in [6] and contained 6.8 g/L YNB, 1 g/L glucose,
170 mg/L l-lysine and 100 mg/L l-histidine. Test medium was
growth medium plus 112 mM CuSO4.  Plate agar was  composed
of YNB (6.7 g/L), casamino acids (10 g/L), adenine (50 mg/L) and
agar (20 g/L) [6].  A  stock solution of RGP (20 mg/mL in DMSO) was
diluted in phosphate buffer (40.8 g/L KH2PO4, 42.6 g/L Na2HPO4,
1.2 g/L MgSO4·7H2O, 3.7 g/L KCl, adjusted to pH 7 with 20% sodium
hydroxide solution) to a concentration of 0.1 mg/mL  to obtain the
substrate dipping solution for pYES [6].  Stock solutions were stored
at −20 ◦C.
2.3. Cultivation of yeast cells for pYES
The cultivation of the yeasts was  performed as described in [6].
Briefly, overnight cultures were prepared by inoculation of growth
medium and incubation for ≥18 h. Test cultures for pYES with a  cell
number of 6–8 × 107 cells/mL were obtained by centrifugation of
the required volume of overnight cultures and re-suspending the
cell pellets in test medium.
2.4.  Planar yeast estrogen screen (pYES)
The pYES was executed on HPTLC glass plates silica gel 60
RP–18 W prewashed with acetone/water (9/1, v/v). The pH value
of the plates was adjusted to about 6.5 with a  solution of sodium
hydrogen carbonate (25 g/L, pH 6.4) as described in [6]. Sample
applications were performed with an Automatic TLC Sampler 4
(ATS4, CAMAG, Muttenz, Switzerland) on  10 cm ×  10 cm  HPTLC
plates (10 mm from the lower edge, 10 mm from the left side,
track distance set  to automatic). To examine the relationship
between dose and response, different volumes of the standard
solutions were applied onto 10 tracks as 5-mm bands result-
ing in amounts of 3, 4, 5,  6, 10, 50, 100, 200, 500 and 1000 pg
per zone for both E2 and EE2. Extracts of water samples (50 mL)
were applied as 5  mm ×  10 mm areas and standard solutions of
E2 and EE2 for calibration as 5-mm bands with amounts of 3, 5,
10, 50, 100, 200 and 500 pg per zone [6]. After application, pYES
was performed as described in [6]. Briefly, the separation of the
analytes was achieved by chromatography, followed by yeast incu-
bation (6–8 × 107 cells/mL, 30 ◦C,  4  h), substrate incubation (0.1 mg
RGP/mL 0.6 M phosphate buffer, pH 7,  37 ◦C, 3 × 30 min), and
documentation of the HPTLC plate. The plates were documented
with a TLC Visualizer (CAMAG) under UV 254 nm, UV 366 nm and
under white light illumination, and scanned with a  TLC Scanner 4
(CAMAG) in fluorescence mode at 550/ >  580 nm (tungsten lamp).
TLC instruments were controlled by the software winCATS, version
1.4.6 (CAMAG).
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2.5. Extraction of  spiked water samples
As recently described [6],  spiked water samples (spiking levels
of 2 ng/L, 6 ng/L, 14 ng/L, and 20 ng/L for both E2 and EE2) were
extracted with TBME. The separated organic phase was evapo-
rated under a stream of nitrogen, and the residue was  dissolved in
ethanol. Subsequently, the pYES was performed as described above.
2.6. Curve-fitting and logit-log plot
Sigmoidal curves were obtained by plotting the peak heights
of the signals against the decadic logarithm of the applied
amount/zone (log amount). For curve-fitting, the software Orig-
inPro (OriginLab, Northampton, USA; version: 2015G Sr2) was
used, when the non-linear curve-fitting model for dose-response
curves with variable hill slope with four parameters (iteration
algorithm for nonlinear regression: Lavenberg-Marquardt, damped
least-squares DLS) was applied. The  function is  described as
y  = A1 +
A2 − A1
1 + 10(LOGx0−x)∗p
(1),
where A1 and A2 are the y  values of the lower and upper asymp-
tote, respectively. LOGx0 gives the point of inflection of the curve
(ED50 =  10
LOGx0) and p is the hill slope. To  form logit values, the peak
heights first had to be normalized (n) to a range between 0 and 1,
employing the bottom and top asymptotes of  the sigmoidal curve
given out by the software:
n =
peak  height − A1
A2 − A1
(2).
The  normalized values were then converted in logits by
logit = ln
(
n
1 − n
)
(3).
Linear  calibration graphs were obtained by plotting the logits
of the calibration standards against the respective log amounts. By
transforming peak heights of the signals of samples to logit-values,
the corresponding log amount could be interpolated from the linear
equation:
logit = a + b ∗ logamount, (4)
where  ‘amount’ is  the amount of EAC per zone, a the y-intercept
and b the slope of  the line.
2.7. ED50 and estradiol equivalents
Values  for the half maximal effect dose (ED50) were calculated
from the linear equation of logit-log plots since the intersection
of the graph with the abscissa (logit =  0)  gives the ED50. Addition-
ally, the ED50 is an output parameter of the software OriginPro,
which determines the value directly from the sigmoidal curves
(ED50 = 10
LOGx0).
The estradiol equivalent factor (EEF) for EE2, which represents
the estrogenic potential of EE2, was determined as follows:
EEF =
ED50 (E2)
ED50 (EE2)
(5).
The  estradiol equivalent concentration (EEQ) of an unknown in
a sample is obtained, when an aqueous sample or a  sample extract
is applied in different volumes onto the HPTLC plate. The aim is
to receive a dose-response curve by plotting the log volumes (mL)
against the peak heights. The EEQ is  then calculated from:
EEQ
(
pg/L ) =
ED50 (E2)
EV50 (unknown) ∗ CF
(6)
where  ED50(E2) is  the half maximal effect dose of E2 (pg/zone),
EV50(unknown) the half maximal effect volume of an unknown EAC
in a  sample, and CF a concentration factor of a possible extraction
process.
3. Results and discussion
3.1.  Dose-response curves
During  the course of HPTLC-pYES, binding of E2 or EE2 results in
an activation of the human estrogen receptor integrated in the yeast
cells, and the activated receptor binds to a  specific DNA sequence,
the estrogen-responsive element of the implemented reporter
plasmid, causing the transcription of the reporter gene and, thus,
the production of b-galactosidase [14,15]. By enzymatic cleavage
of the substrate RGP, orange fluorescent resorufin is  released, indi-
cating the estrogenic activity of a substance. Plate images and a
3D densitogram of the fluorescence scan of an HPTLC-pYES for E2
and EE2 exemplarily are shown in Fig. 1. To examine the dose-
response relationship of E2 and EE2, the obtained peak areas and
peak heights were plotted against the amount (pg/zone) and the
log amount, respectively, exemplarily shown for EE2 (Fig. 2). Since
a ligand-binding reaction usually shows saturation, a  typical sig-
moidal curve should be observed in a  semi-log plot. However, such
typical dose-response curves were not obtained when peak areas
were used. Instead, the signal steadily increased with an increas-
ing amount per zone, irrespective of the used units (Fig. 2A and  C),
while simultaneously the zones became wider and wider due to
overloading the layer (Fig. 1). It first was  supposed that the high
cell density was  the reason for the obtained dose-response curves.
Therefore, the experiments were repeated with a  lower number of
yeast cells, but the course of the curve did not change (data not
shown). The peak area is proportional to the total amount of the
substance over the whole zone and, therefore, increases with the
widening of the zones. By contrast, the peak height is in a way lim-
ited since it only represents the maximum of the signal regardless
its width. Hence, the peak heights were plotted against the amount
per zone, when the curve indeed showed saturation (Fig. 2B). A
typical sigmoidal curve was  then successfully obtained, when peak
heights were plotted against the decadic logarithm of the amount
per zone (Fig. 2D).
3.2.  Logit-log plots and working range
The presence of sigmoidal dose-response curves with upper and
lower asymptotes enabled linearization of the data by means of the
logit-log method. For this purpose, the peak heights first were nor-
malized to a scale from 0 to 1 (Eq. (2)). This required a preceding
curve-fitting to determine the lower and upper asymptotes of the
sigmoidal curves, which was performed employing the software
OriginPro. Subsequently, logits were calculated from the normal-
ized values (Eq. (3)). Fig. 3 shows the sigmoidal curves for E2 and
EE2, when the mean peak heights of five standard calibrations were
plotted against the corresponding log amounts in a  range of 5–500
pg/zone. After transformation of the data into logits, a  linear graph
(logit-log plot) was obtained (Fig. 3).
The linear logit-log plots for both E2 and EE2 showed good lin-
earity over two  decades (5–500 pg/zone). Linear calibration graphs
determined on  five days with both new HPTLC plates and yeast cell
suspensions, resulted in coefficients of correlation (R2) between
0.9324 and 0.9990 for E2 and  between 0.9877 and 1.0000 for EE2,
with means of 0.9927 and  0.9997, respectively (Fig. 3). Compared to
former results with polynomial regression and a working range up
to 200 pg/zone [6], logit-log plots provided an expanded working
range up to 500 pg/zone, which is of  great advantage for the screen-
ing of  samples with unknown concentrations of EAC. The extension
of the working range with higher and lower calibration standards is
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Fig. 1. pYES on HPTLC RP–18 W plates for the  determination of the  dose-response relationship. Plate images under UV 254 nm (A) and white light illumination (B), and
corresponding 3D densitogram (C) of the fluorescence scan (550/ > 580 nm). Enzymatic cleavage of the substrate RGP releases resorufin, detectable as orange fluorescent
zones under UV and pink zones under white light. (For interpretation of the  references to  colour in this figure legend, the reader is referred to the  web version of this article.)
Fig. 2.  Dose-response curves exemplarily shown for EE2 (n = 9).
possible as far as a logit-log plot can be formed from the sigmoidal
curves. However, it has to be in mind that the highest and lowest
calibration standards are limited by the upper and lower asymp-
totes. Computed values for the upper and lower asymptotes can be
lower or higher, respectively, than the highest or lowest standard
signals, why logit values cannot be calculated from these signals,
thus limiting the working range.
3.3. Using logit-log plots to calculate recovery rates
In  an earlier study, water samples were spiked at  four differ-
ent levels (2–20 ng/L), and the extracts were applied on an HPTLC
plate  resulting in amounts of about 15, 45, 105, and 150 pg/zone
for both E2 and EE2 [6]. Subsequently, HPTLC-pYES was  performed,
and recoveries were determined by a  polynomial calibration func-
tion (using peak areas) in a working range up to 200 pg/zone for E2
and EE2. In the present study, recoveries for the same spiked water
extracts were re-analyzed by means of logit-log plots using the peak
height of the signals of calibration standards up to 500 pg/zone.
Mean recoveries were determined to 90 ±  6% for E2 and 108 ± 10%
for EE2 (Table 1) with mean relative standard deviations (RSD) of
17 ±  5%.  Thus, recoveries were not identical but rather similar to the
results of the former study (mean recovery rates of 100 ± 6% for E2
and 107 ± 4% for EE2 with mean RSD of 18 ± 3%  [6]). It should be
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Fig. 3. Dose-response curves with upper and lower asymptotes (n  = 5) and respective logit-log plots for E2 and EE2; corresponding ED50 is given by the  point of inflection of
the  curve and the intersection with the abscissa, respectively.
Table 1
Recoveries for E2 and EE2 from spiked water samples, calculated by logit-log plots (n = 5).
Substance Spiked level
[ng/L]
Determined  concentration
[ng/L]
Recovery
[%]
RSD
[%]
E2 2.0  1.9 97 20
6.0 5.7 95 19
13.9 11.8 85 11
19.8 16.4 83 24
EE2 2.0 2.4 123 19
6.0 6.1 102 10
13.9 13.7 98 13
19.9 21.4 107 22
mentioned that the spiking levels fitted to the lower, nearly linear
part of the polynomial calibration curve [6]. Errors expressed as
RSD would increase for spiking levels at  the upper flattened part
of the calibration curve, and a fortiori at  levels above 200 pg/zone
(Fig. 2A). That is the profit of logit-log providing a  consistent linear
function with a clear slope in the defined working range up to 500
pg/zone.
3.4. ED50, EEF, and EEQ
Sigmoidal  dose-response curves also allowed the determination
of the half maximal effect dose (ED50) [4] instead of an EC50 used
in microtiter plate assays and, therefore, the estrogenic potential of
an  EAC in relation to E2, expressed as estradiol equivalent factors
(EEF).
The ED50 for E2 and EE2 were determined from the logit-log
plots, when the logits of  the peak heights of five standard calibra-
tions were plotted against the decadic logarithm of the respective
applied amounts per zone. The intersection of the linear graph with
the abscissa (logit =  0) represents the ED50 of an EAC. Thus, for E2
and EE2, the ED50 were calculated to 47 ±  8 and 74 ±  12 pg/zone
(n = 5), respectively. By means of ED50 values, the estradiol equiv-
alent factor (EEF) of EE2 was determined to 0.64 ± 0.07 (n =  5). In
literature, the EEF for EE2 determined by YES according to [1] was
reported as 0.9 (0.44-2.1, n  =  3) [2]. EEF values for EE2 in other pYES
studies were reported to 0.3 [5] and 0.44 [17]. Additionally, the
ED50was determined by the software OriginPro from the sigmoidal
curves, when again the peak heights of five standard calibrations
were plotted against the respective log amounts. As the result,
ED50 of 50 ± 8 and 74 ± 11 pg/zone (n =  5)  were determined for E2
and EE2, respectively, well correlating to the values obtained from
the logit-log function. The determined EEF for EE2 was  0.68 ± 0.03
(n =  5) and, thus, was also well comparable to the value determined
from the logit-log plot.
In  microtiter plate assays, dose-response curves moreover are
used for the determination of estradiol equivalent concentrations
(EEQ), which are defined as the ratio of the EC50 of the reference E2
and the EC50 determined from the dilution dose-response curve
of a sample, when different sample volumes are applied to the
microtiter plate assay, considering any enrichment or dilution fac-
tors. The so-called EC50 method provides a  standardized method
for the analysis of bioassays [18]. To estimate the EEQ, the concen-
tration at EC50 of the reference E2 is divided by the product of  the
dilution at the EC50 of the sample and the enrichment factor of a
possible extraction [18]. This method should also be transferable
to HPTLC-pYES. Therefore, the sample has to be applied in different
volumes, and the log volumes are plotted against the correspond-
ing signals to obtain a  dose-response curve for an unknown EAC.
Subsequently, the half maximal effect volume (EV50) is  determined
from the sigmoidal or logit-log curve. Dividing the ED50(E2) by the
EV50(unknown), the EEQ is obtained expressed as pg/mL sample or
sample extract (Eq. (6)). Thus, for HPTLC-pYES, the EEQ allows to
estimate the estrogenic power of  a distinct (separated) unknown
EAC, while for YES assays in microtiter plates, the EEQ only repre-
sents the total estrogenic activity of a  sample.
4. Conclusions
Proper sigmoidal dose-response curves from HPTLC-pYES were
obtained after plotting the peak height of  resorufin fluorescence
signals against the decadic logarithm of  the applied amount of
17b-estradiol (E2) and 17a-ethinylestradiol (EE2), respectively.
The obtained sigmoidal dose-response curves for E2 and EE2 were
successfully transformed into linear logit-log plots, enabling the
determination of E2 and EE2 up to 500 pg/zone. This provides a
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wide working range, which is greatly advantageous for the anal-
ysis of samples with unknown concentrations of estrogen active
compounds (EAC). Logit-log plots with linear graphs allow an easy
way of interpolation and also the easy determination of the half
maximal effect dose (ED50). With knowledge of ED50 values for
EAC, the determination of estradiol equivalent factors (EEF) of pure
compounds and the estradiol equivalent concentration (EEQ) of
unknown EAC is possible by HPTLC-pYES.
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a b  s  t  r  a c t
Hops  used  in  the  brewing  process  of  beer for flavoring  are  known  to contain  estrogen  active  compounds
(EAC)  and to be the source  of  EAC in  beer.  The recently  developed  planar yeast  estrogen screen  (pYES)  with
the  substrate resorufin-b-d-galactopyranoside  (RGP)  successfully  was applied  for  the  detection  of  EAC
in  ethanolic extracts of  hops  pellet  samples. The only  pYES  positive  compound  was  identified  as  the  hop
flavanone  prenylnaringenin  (PN) by  thin-layer  chromatography–mass  spectrometry.  The heat-induced
formation  of estrogen  active  PN  from  the  inactive hop  flavonoid  desmethylxanthohumol  was  confirmed
by  simulation of  wort  boiling, extraction  of  both  the  hops’  remainder and  the  supernatant water, and
subsequent  investigation of  the extracts  by  pYES.  By  means  of  the dose-response  curve  of PN  of  a hops’
remainder  extract, the  estradiol  equivalent  concentration (EEQ)  and thus  the estradiol  equivalent  amount
(EEA)  of  PN  in  the  hops’  remainder after simulation  of  the  wort  boiling  was  determined  to 39 mg/L  and
52  mg/kg,  respectively.
© 2017 Elsevier  B.V.  All rights reserved.
1. Introduction
The presence of estrogen active compounds (EAC) in hops is
known for years and impacts on humans were observed as, for
example, female hops pickers suffered from menstrual distur-
bances [1]. Milligan et  al. identified four hop flavonoids as EAC, the
prenylflavanones 8-prenylnaringenin (8-PN), 6-prenylnaringenin
(6-PN) and 6,8-diprenylnaringenin, and the geranylated flavanone
8-geranylnaringenin, when 8-PN was identified as the most potent
phytoestrogen [2,3]. The  major hop flavonoid is xanthohumol (XN),
while other flavonoids only occur in trace amounts [4], but the for-
mation of isoxanthohumol (IXN) from XN and the estrogen active
compounds 6-PN and 8-PN from desmethylxanthohumol (DMX) –
inter alia during the brewing process of beer –  was reported [5,6].
Thus, more prenylflavanones (partly with estrogenic activity) than
prenylchalcones occur in beer [7].
In the present work, hops pellet samples were extracted with
ethanol, and the extracts were investigated by planar yeast estro-
gen screen (pYES) to detect EAC [8]. Additionally, a  part of the
brewing process was simulated to verify the possible formation
of EAC during heat supply in aqueous solutions. Both the hops’
∗ Corresponding author.
E-mail address: wolfgang.schwack@uni-hohenheim.de (W.  Schwack).
remainder and the aqueous phase were extracted, analyzed by
pYES, and the results compared to them obtained with the orig-
inal hops samples. The applied pYES provided the separation of the
samples by high-performance thin-layer chromatography (HPTLC)
prior to the bio-detection by yeast cells of a recombinant yeast
strain of S.  cerevisiae generated by  McDonnell et al. [9,10], con-
taining the human estrogen receptor and a reporter gene that
encodes for b-d-galactosidase. By cleavage of the suitable substrate
resorufin-b-d-galactopyranoside (RGP) by the enzyme that is pro-
duced in presence of EAC, orange fluorescent resorufin is released
in the HPTLC zone allowing the clear detection of an estrogenic
activity of a  substance [8]. Moreover, detected EAC were identified
by HPTLC coupled to electrospray ionization mass spectrometry.
In  a recent work, the applicability of the logit-log method as
evaluation tool for pYES was  demonstrated, allowing the easy
determination of half maximal effect doses (ED50) of EAC and the
calculation of estradiol equivalent factors (EEF), using the example
of 17a-ethinylestradiol (EE2), a  synthetic estrogen used in contra-
ceptives [11]. Additionally, the use of pYES for the estimation of
estradiol equivalent concentrations (EEQ) of  unknown EAC in liquid
samples or sample extracts with the EC50 method was  taken into
account [11]. These calculations were used in the present study
to exemplarily estimate the EEQ of hops’ remainder extracts and
hence the estradiol equivalent amount (EEA) of the hops’ remain-
der.
https://doi.org/10.1016/j.chroma.2017.11.069
0021-9673/© 2017 Elsevier B.V. All rights reserved.
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2. Materials and methods
2.1.  Chemicals and materials
The  following chemicals and materials were from Merck (Darm-
stadt, Germany): potassium chloride (>99%), potassium dihydrogen
phosphate (p.a.), copper(II) sulfate pentahydrate (p.a.), sodium
hydroxide solution (20%), disodium hydrogen phosphate (p.a.), l-
histidine (≥99%), hydrochloric acid (37%), and HPTLC glass plates
silica gel 60 RP-18 W (200 mm × 100 mm,  layer thickness 200 mm).
Yeast nitrogen base without amino acids (YNB), casamino acids
[12], adenine and agar for plate agar were from Becton Dickinson
(Heidelberg, Germany). YNB without amino acids for liquid culture
media, ethanol (≥99.8%), and methanol (≥99.9%) were obtained
from Sigma-Aldrich (Steinheim, Germany). d-Glucose (anhydrous)
and sodium hydrogen carbonate were purchased from BDH Pro-
labo Chemicals (VWR, Bruchsal, Germany). Ammonium formate
(≥99%), acetonitrile (≥99.9%), diethyl ether (≥99.8%, ∼2% ethanol as
stabilizer), l-lysine (≥98%), and magnesium sulfate heptahydrate
(puriss. p.a.) were obtained from Fluka-Sigma-Aldrich (Stein-
heim, Germany). Resorufin-b-d-galactopyranoside (RGP) was from
Santa Cruz biotechnology (Dallas, USA), formic acid (98%) and
dimethyl sulfoxide (DMSO, 99.98%) from Fisher Scientific (Schw-
erte, Germany). Acetone (≥99.8%) was from Carl Roth (Karlsruhe,
Germany). Ultrapure water was supplied by a  Synergy System
(Millipore, Schwalbach, Germany). Yeasts of the strain Saccha-
romyces cerevisiae BJ3505 (protease deficient, MATa,  PEP4::HIS3,
prb1-11.6R, HIS3-1200, lys2-801, trp1-1101, ura3-52gal2can1)
for pYES were generated by McDonnell et al. [9,10] and stored in
a cryo-vial at −70 ◦C.  Orange filter glass O  580 from HEBO (Aalen,
Germany) was used as optical filter for the TLC  Scanner 4 (CAMAG,
Muttenz, Switzerland).
2.2.  Media, agars and cultivation of  the yeasts
Media and agars were composed as described in an earlier pub-
lication [8]: growth medium consisted of 6.8 g/L YNB, 1 g/L glucose,
170 mg/L l-lysine and 100 mg/L l-histidine. Test medium addi-
tionally contained 112 mM CuSO4.  Plate agar was composed of
YNB (6.7 g/L), casamino acids (10 g/L), adenine (50 mg/L) and agar
(20 g/L). Cultivation of yeasts was performed as described in [8].
Briefly, for overnight cultures, growth medium was inoculated with
a colony from an agar plate and incubated overnight. Test cultures
were prepared by centrifuging the required volume of overnight
cultures and re-suspending the cell pellets in test medium. The
cell number was measured with a  TC20 automated cell counter
(Bio-Rad Laboratories, Munich, Germany).
2.3. Substrate solution
Substrate  dipping solutions with a  concentration of  0.1 mg
RGP/mL were prepared by diluting 200 mL of a stock solution of
RGP (20 mg/mL  in DMSO, stored at −20 ◦C) in 40 mL phosphate
buffer consisting of 40.8 g/L KH2PO4, 42.6 g/L Na2HPO4,  1.2 g/L
MgSO4·7H2O, 3.7 g/L KCl (adjusted to pH  7  with 20% sodium
hydroxide solution) [8].
2.4.  Planar yeast estrogen screen (pYES)
HPTLC glass plates silica gel 60 RP-18 W  were prewashed with
acetone/water (9/1, v/v), heated for 30 min  at 120 ◦C on  the TLC
Plate Heater III (CAMAG) and cooled down afterwards. To adjust
the pH value of the plates to about 6.5, the plates were pre-
treated with a solution of  sodium hydrogen carbonate (25 g/L,
pH 6.4) [8]. Sample extracts were applied as 8 mm × 20 mm  areas
with an Automatic TLC Sampler 4 (ATS4, CAMAG) onto 10 × 10 cm
HPTLC  plates (15 mm from the lower edge, 12 mm from the left
side, track distance set to automatic). The application zones were
focused with acetonitrile up to 25 mm in a  twin-trough chamber
(10 cm × 10  cm,  CAMAG). Chromatography was  performed with a
mixture of MeOH/H2O (3/2, v/v) up to a  migration distance of
70 mm  using an Automatic Developing Chamber 2 (ADC2, CAMAG).
Afterwards, yeast incubation (6–8 × 107 cells/mL, 4  h, 30 ◦C) and
substrate incubations (RGP in 0.6 M phosphate buffer, 0.1 mg/mL,
pH 7, 3 × 30 min, 37 ◦C) were performed as described in the earlier
work [8]. HPTLC plate documentation was performed with a TLC
Visualizer and a  TLC Scanner 4 (both CAMAG). Plate images were
captured under UV 254 nm,  UV 366 nm and white light illumina-
tion, and the HPTLC plates were scanned in fluorescence mode at
550/ >  580 nm (tungsten lamp). TLC instruments were operated by
the software winCATS, version 1.4.6 (CAMAG).
2.5. Samples and extraction
Hops  pellet samples were obtained from the Distillery for
Research and Training, University of Hohenheim, Germany. Two
samples without further information about the hop variety were
from Germany (hops A and B), one sample was from Great Britain
(variety First Gold) and one from the USA (variety Galena). The hops
pellets were ground in a  mortar before extraction. The pestled hops
sample (0.15 g) was  extracted with ethanol (1 mL) by sonication
for 10 min, followed by centrifugation at  13,000g for 5 min. The
supernatant extract was  evaporated in a nitrogen stream and the
residue dissolved in 200 mL of ethanol. Subsequently, the extract
was applied (4 mL) onto an HPTLC plate and subjected to pYES as
described above (2.4 pYES). Additionally, the wort boiling part of
the brewing process was simulated by cooking the pestled hops
(0.15 g) in water (0.1 L)  for one hour under constant stirring. In
parallel, this process was  also performed without heating. After
centrifugation, the hops’ remainders were extracted with ethanol
as described above. The supernatant aqueous extract (1  mL) was
extracted with diethyl ether (2 mL)  by vortexing for 2 min [13]. The
separated organic phase was  evaporated by a  nitrogen stream, and
the residue was dissolved in 200 mL of ethanol. After the applica-
tion of the extracts (4 mL of  the hops’ remainder extracts, 60 mL  of
the ether extracts of the supernatant water), pYES was performed
as described above (2.4 pYES).
2.6. High-performance thin-layer chromatography–mass
spectrometry
An ethanolic extract of the hops’ remainder after boiling was
applied onto an HPTLC plate (2-fold application of 4, 6, and 8 mL)
that was cut into two sections after chromatography. One sec-
tion of the plate was used for pYES, whereafter the coordinates
of active zones were transferred to the other plate section used
for mass spectrometry. Zones of interest (8 mL application) were
eluted with the oval elution head of a  TLC-MS interface (CAMAG)
using methanol/ammonium formate buffer (10 mM,  pH 4, 98:2,
v/v [13]) and the eluate was  transferred online at  a  flow rate of
0.2 mL/min (pump: Jasco PU-980, Groß-Umstadt, Germany) to a
single quadrupole mass spectrometer (G1956B MSD, Agilent Tech-
nologies, Waldbronn, Germany) equipped with an electrospray
ionization (ESI) interface. For negative ionization the following
parameters were used: capillary voltage 3.0 kV, drying gas tem-
perature 300 ◦C, drying gas flow rate 10 L/min, and nebulizer gas
pressure 40 psig. Mass spectra in negative scan mode were recorded
in a range of m/z 150 to m/z 450 with a fragmentor voltage of 100 V,
gain 2.0, a step size of 0.1 and threshold 100. Data was recorded with
the software ChemStation B.02.01 SR2 (Agilent Technologies).
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Fig. 1.  Work flow of pYES (experimental conditions and details see chapter 2.4).
Fig. 2. Plate images of pYES steps for hops extracts (hops B) after direct extraction with ethanol (A)  and after extraction of the hops’ remainder after simulation of wort boiling
(B);  1: after application under 366 nm illumination, 2: after focusing under 366 nm illumination, 3: after chromatography under 366 nm  illumination, 4: after yeast incubation
under 366 nm illumination, 5: after substrate incubation under 254 nm illumination, 6: after  substrate incubation under white light illumination. (For interpretation of the
references to colour in the text, the reader is referred to the  web  version of this article.)
2.7. Half maximal effect volume, estradiol equivalent
concentration and estradiol equivalent amount
To estimate the estradiol equivalent amount (EEA) in the hops’
remainder after simulation of the brewing process, the ethano-
lic extract of the hops’ remainder (hops B) was 10-fold diluted
with ethanol and applied as 8 mm × 20 mm areas in different vol-
umes (2–40 mL) onto an  HPTLC plate, followed by pYES (2.4 pYES).
The obtained peak heights of  the EAC signals were plotted against
the decadic logarithms of the respective application volumes. The
resulting sigmoidal dose-response curve was fitted and the upper
and lower asymptotes of the curve were determined using the
software OriginPro (OriginLab, Northampton, USA; version: 2015G
Sr2). With knowledge of the lower and upper asymptotes, a logit-
log plot for the EAC in the hops’ remainder was created as described
in an earlier work [11]. From the logit-log plot, the half maximal
effect volume (EV50) of the EAC was determined (intersection with
the abscissa) and consequently the estradiol equivalent concentra-
tion (EEQ) of the hops’ remainder extract was calculated as follows:
EEQ(pg/L) =
ED50(E2) ∗ DF
EV50(EAC)
, (1)
where  ED50(E2) is  the half maximal effect dose of E2 (pg/zone) and
DF is the dilution factor of  the extract applied. The EEA of the spent
hops was then estimated from:
EEA(g/kg) =
EEQ(g/L)
cont(kg/L)
, (2)
where  cont represents the content of hops’ remainder in the extract.
3. Results and discussion
3.1.  Estrogen active compounds in hops
Ground hops pellets were extracted with ethanol and the extract
was investigated by pYES (schema of pYES steps see Fig. 1).
Milligan et al. identified the four flavanones 8-prenylnaringenin
(8-PN), 6-prenylnaringenin (6-PN), 8-geranylnaringenin and 6,8-
diprenylnaringenin as estrogen active compounds (EAC) in hops
[3]. However, only one HPTLC zone with estrogenic activity was
observed in the extract of the pestled hops sample as very weak
orange fluorescing zone under 254 nm illumination (Fig. 2A, track
5) and very weak pink zone under white light illumination (Fig. 2A,
track 6), respectively. Since 80–90% of the flavonoids of hops were
determined as xanthohumol (XN), and estrogen active flavonoids
only occur in trace amounts [4,14], a  low amount of  EAC in the hops
extract and, thus, only weak signals were expected. Moreover, the
estrogenic activity of 8-PN was  reported to be considerably higher
than the activity of  the other detected estrogenic hop flavonoids
[2,3], why it  was plausible to obtain only one HPTLC zone showing
estrogenicity after pYES.
3.2.  Direct extraction versus extraction after simulation of wort
boiling
Pestled  hops pellets were extracted with ethanol and  the
extracts were compared to extracts of the hops’ remainder after
the simulation of wort boiling. Plate images of  the pYES steps are
shown in Fig. 2.  In both extracts only one HPTLC zone with estro-
genic activity was  observed, indicated by orange fluorescence of
released resorufin (Fig. 2, tracks 5). However, the orange fluorescing
HPTLC zone of the hops extract became much more clear and inten-
sive after heating in water (Fig. 2B, track 5  versus Fig. 2A, track 5).
The treatment with water also acted like a  pre-extraction cleanup
leading to the removal of some matrix compounds, clearly to see,
since the hops’ remainder extract showed less native fluorescing
zones compared to the extract of the original hops sample (Fig. 2B,
track 3  versus Fig. 2A, track 3). The formation of prenylflavanones
from their chalcones during the brewing process, including the iso-
merization of inactive desmethylxanthohumol (DMX) to estrogen
active 6-PN and 8-PN (Fig. 3), respectively, was reported [5,6,15].
In agreement with the reports, the heat treatment in water led to
the formation of a higher amount of EAC detected by pYES, simul-
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Fig. 3. Isomerization of desmethylxanthohumol (DMX) to 8-prenylnaringenin (8-PN) and 6-prenylnaringenin (6-PN), and isomerization of xanthohumol (XN) to isoxantho-
humol (IXN).
Fig. 4. Plate images of extracts of hops B’  remainders and extracts of the  supernatant water after chromatography under 366 nm illumination (A), after yeast incubation
under white light illumination (B), after substrate incubation under 254 nm illumination (C); extracts of hops’ remainders after cold (1) and hot (2)  water treatment, extracts
of  the supernatant water after cold (3) and hot (4) treatment.
taneously showing the advantage of the application of an HPTLC
method since different samples can  be applied in parallel and dif-
ferences in the amounts of detected EAC are instantly observable
at one look. The experiments show the great advantage of  RGP
as pYES substrate, when blue fluorescing matrix compounds do
not interfere with the detection of EAC, as it is  to be respected,
if 4-methylumbelliferyl-b-d-galactopyranoside is used [13].
3.3.  Impact of hot/cold water
Hops samples were stirred in cold and hot water for one hour,
whereafter the hops’ remainders were extracted with ethanol.
According to Klingelhöfer and Morlock [13] the supernatant water
phases were extracted with diethyl ether. As seen in Fig. 4C, the
EAC was detectable in the extracts of the hops’ remainders of both
the cold and hot water treatment, but clearly increased after heat
treatment. The EAC was also clearly be detected in the aqueous
phase after heat treatment, but the aqueous phase extract of the
cold water treatment did not show any zone of estrogenic activity.
Thus, a transfer of the EAC into water occurred under heat treat-
ment (comparable to the brewing process), but obviously not into
cold water, or the amount of EAC in the cold water extract was  too
low to be detected.
Stirring  in cold water slightly decreased the amount of matrix
substances in the hops’ remainders extract (Fig. 4A, track 1 versus
Fig. 2A, track 3, and Fig. 4C, track 1 versus Fig. 2A, track 5), while
additional heating not only increased the aqueous extraction of
matrix substances (Fig. 4A, track 2 versus track 1), but also  the
amount  of EAC in the hops’ remainder (Fig. 4C, track 2 versus track
1).
The application of an HPTLC method provides the advantage to
see all  extracted sample components at one look. Hence, differences
in the amount of the components can be seen directly on  the plate,
especially to be seen in the extracts of the hops’ remainder under
UV 366 nm illumination. The  extract of the hops’ remainder after
the cold water treatment showed a  couple of zones of blue and  red
fluorescing compounds (Fig. 4A, track 1), which clearly changed
in composition after the hot water treatment (Fig. 4A, track 2).
Especially the large zone of a red fluorescing compound nearly dis-
appeared, which was, among other compounds, recovered from the
ether extracts of the aqueous phase (Fig. 4A, track 4).  Thus, heating
supported the extraction of  this compound from the hops during
the stirring in water. As already mentioned above, Fig. 4  also sup-
ports the clear distinguishability between native fluorescences of
sample components and estrogenic activity signals indicated by the
orange fluorescing resorufin and the advantage to see differences
in amounts of EAC on the plate at  once.
3.4. Mass spectrometry
After  chromatography of the hops’ remainder extract of hops B
(after heating in water), three yellow HPTLC zones were observed
(Fig. 5A, track 2),  one of  which showed estrogenic activity after
pYES indicated by orange fluorescence (Fig. 5A, track 1). The HPTLC
zones were eluted into a mass spectrometer equipped with an elec-
trospray ionization (ESI) interface.
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Fig. 5. Images of tracks for HPTLC-MS (A) and corresponding mass spectrum of the  HPTLC zone showing estrogenic activity (B); 1: track after pYES under UV 254 nm
illumination for transfer of the coordinates of the  estrogen active zone, 2: track after chromatography under white light illumination used for MS.  The deprotonated molecule
at m/z  339 confirm the EAC to be prenylnaringenin. Further signals result from the  HPTLC plate material and impurities of the used chemicals, respectively. (For interpretation
of  the references to  colour in the text, the reader is referred to the web  version of this article.)
In negative ionization mode, the HPTLC zone with estrogenic
activity showed a  mass signal at m/z  339 for the deprotonated
molecule, corresponding to the isobaric 6-PN, 8-PN or DMX. Since
i) DMX isomerizes completely within 15 min  in the brewing kettle
[5] and is not known to be estrogen active, ii) 6-PN only showed
a weak estrogenic activity (EC50 determined by YES according to
[16] was a hundred times greater compared to 8-PN [2]), and iii)
8-PN was identified as the most potent phytoestrogen [2], the
detected mass of the EAC was assumed to correspond to 8-PN.
Besides, Milligan et al. determined the estrogenic activity of 6-PN,
6,8-diprenylnaringenin and 8-geranylnaringenin as very weak and
thus stated 8-PN as major compound providing the estrogenicity of
hops [3]. However, since there is  no clear evidence for the assign-
ment to 8-PN without additional spectroscopic data and DMX  can
most probably be excluded since it does not show estrogenic activ-
ity and would isomerize during heat apply, the EAC is  named solely
‘PN’ hereafter.
The  aim of TLC-MS, however, was to confirm the EAC detected
by pYES to be the known EAC (8-PN) of hops. Generally, the power
of pYES as screening tool was demonstrated, since it  was shown a
fast and easy non-target screening (no need of standard substances,
when up to 20 samples can be analyzed in one run on 20 cm × 10 cm
HPTLC plates) to detect EAC in sample extracts after a simple sample
extraction without further steps of working up or purification. This
was exemplarily shown for ethanolic extracts of hops pellet sam-
ples to investigate other samples than water samples (as already
shown in [8]). Thus, it was shown, with another matrix, the detec-
tion of EAC was also possible and the differentiation between native
fluorescence and fluorescence due to estrogenic activity was  given.
Moreover, the possibility for an identification of unknowns by cou-
pling HPTLC to MS  was shown. Additionally, for the first time, the
application of the EC50-method in an HPTLC analysis (see chap-
ter 3.6) to estimate the estrogenic potential of a sample or single
sample compounds in terms of estradiol equivalents was  demon-
strated, for which, however, the identity of an EAC does not have
to be necessarily known.
Additionally  to the EAC, the upper and lower natively yellow
zones (Fig. 5A, track 2)  were analyzed and showed mass signals
at m/z 361 ([M−H]−)  and m/z  353 ([M−H]−), respectively. The
signal at m/z  353 conforms to the deprotonated molecule of the
prenylchalcone XN  and the prenylflavanone isoxanthohumol (IXN),
respectively, and the mass signal at  m/z  361 is assumed to be the
deprotonated molecule of the alpha acids humulone or adhumu-
lone, which are crucial for the bitter taste of beer [17]. Since not
only  DMX  isomerizes to 6- or  8-PN during heat treatment, but also
XN isomerizes to IXN (Fig. 3) [5,15], the zone providing m/z 353 is
assumed to match IXN. Besides, Stevens et al. identified IXN as the
main prenylflavonoid in beer [7], why it is  plausible that IXN is  also
the main prenylflavonoid after cooking of hops in water. Further-
more, the zone with m/z 353 (XN/IXN) showed the most intensive
yellow HPTLC zone (Fig. 5A, track 2). IXN was reported to be a  proe-
strogen, which can be converted to 8-PN by O-demethylation by
specific microbiota in the human intestine [18,19], which is  of inter-
est since the consumption of beer thus can lead to a  higher exposure
with EAC than expected from the analysis of beer [18].
3.5.  pYES of different hop varieties
Klingelhöfer et  al. already screened different samples of beer,
aroma hops and bitter hops (Hallertau hops) for the presence of EAC
by means of a  pYES using the substrate 4-methylumbelliferyl-b-
d-galactopyranoside indicating estrogenic activity by the released
blue fluorescing 4-methylumbelliferone [20]. Beer samples were
extracted with diethyl ether and pestled hops pellets with a mixture
of ethanol/methanol/acetone at 60 ◦C  [20]. After pYES, the beer and
hops extracts showed up to 3 zones with estrogenic activity [20].
For the present study, four pestled hops pellets from different
hop varieties (2 samples from Germany, one from Great Britain
and one from the USA) were cooked in water for 1  h, the hops’
remainders were extracted with ethanol, and the extracts were
examined by pYES. All four extracts only showed a single estrogen
active zone after pYES (at  the hRF of prenylnaringenin), but of dif-
ferent intensity (Fig. 6).  Hops B (Germany) and the Galena variety
(USA) showed more intensive EAC zones than hops A  (Germany)
Fig. 6. 3D  densitogram of the fluorescence scan at  550/ > 580 nm after pYES of hops’
remainder extracts after simulation of the  wort boiling of four different hop varieties.
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Fig. 7. Dose-response curve and respective logit-log plot for PN in an extract of hops B’ remainder after boiling in water; corresponding EV50 is  given by the point of inflection
of the curve and the intersection with the  abscissa, respectively.
and the First Gold variety (GB). The differences as compared to
the results of Klingelhöfer et al. [20] possibly are due to different
pretreatments of hops (cooking in water versus no  pretreatment)
and both different extractions (cold ethanol, ultrasonic bath versus
hot ethanol/methanol/acetone) and chromatographic conditions
(mobile phase).
Most,  if not all PN in hops extracts and beer is formed by iso-
merization from DMX  (spontaneous cyclization or dependent on
storage, medium, heat treatment) [6,14,15]. In the brewing kettle,
DMX generally is converted to 6- or 8-PN (Fig. 3), and no  DMX
or only trace amounts are detectable in beer itself [7]. The  abun-
dance of DMX  of the total resin flavonoids was determined in 11
different European hop varieties to 2–3% [4]. In another study, DMX
was determined in  a range of 0.12–0.39% (w/w) in full-grown hop
cones of five hop varieties that are used for brewing different ales or
bitters [21]. Therefore, the intensity differences of the pYES zones
showing estrogenic activity are assumed to be due to the different
hop varieties, including different storage times, which are respon-
sible for different amounts of DMX  and, thus, for different amounts
of PN after boiling.
3.6.  Estimation of the estradiol equivalent amount in the hops’
remainder after simulation of  the brewing process
To determine the estradiol equivalent amount (EEA), a  hops B
sample as example of high EAC hops was submitted to a simu-
lated brewing process, and the hops’ remainder was extracted with
ethanol. Plotting the pYES signals against the decadic logarithms
of different application volumes of the hops’ remainder extract, a
sigmoidal dose-response curve for the EAC, identified as PN, was
obtained (Fig. 7). The presence of a  sigmoidal curve allowed the
transformation into a  logit-log plot and hence the easy determina-
tion of the half maximal effect volume (EV50) of  the EAC (Fig. 7).
The EV50 for PN in the hops’ remainder extract was determined to
12 mL from the linear logit-log graph. With the EV50 value and the
dilution factor (DF = 10) and with the half maximal effect dose of
47 pg/zone for E2 [11], the calculation of the estradiol equivalent
concentration (EEQ, Eq. (1)) of the hops’ remainder extract was  cal-
culated to 39 mg/L. Additionally, the estradiol equivalent amount
(EEA) of the hops’ remainder was estimated (Eq. (2)), resulting in
52 mg/kg, i.e. the amount of PN per kg  hops after cooking showed
an estrogenic activity as compared to 52 mg E2 per kg.
4.  Conclusions
The recently developed RGP-pYES was successfully applied
on hops samples, and the distinct aspects of  the advantageous
application of the developed screening based on the chromato-
graphic separation of sample components by HPTLC in combination
with a bioassay to detect estrogen active compounds were pre-
sented. Thus, estrogen active zones were clearly differentiable
from zones of sample constituents with native fluorescence (blue,
red), demonstrating the advantageous usage of  the substrate RGP.
Prenylnaringenin (PN) was identified and confirmed as estrogen
active compound after ethanolic extraction of pestled hops pellets
and hops’ remainders after simulation of  the wort boiling, showing
the possibility to couple pYES to MS to identify unknown EAC. Addi-
tionally, heat induced formation of prenylnaringenin was shown,
when the advantage of the application of a  planar system became
clear since all components of a sample are to be seen at  one look
on the HPTLC plate and  differences in amounts of  components are
observable at once. Moreover, by creating the dose-response curve
and thus the logit-log plot for PN, and by employing the EC50-
method (first time use in HPTLC), the possibility to estimate the
estradiol equivalent concentrations (EEQ) and the estradiol equiv-
alent amounts (EEA) of single EAC in liquid or solid samples was
demonstrated.
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III Discussion
With respect to the watch list of substances for Union-wide monitoring in the field of water 
policy of the European Commission (2015), which inter alia contains four estrogen active 
compounds (EAC), and with regard to the great number of EAC that occur in our 
environment, suitable screening methods for estrogenic activity are of great interest. For the 
determination of EAC, several methods are available. Many of these methods, however, only 
give a statement about the whole bioactivity of a sample as a sum or represent a targeted 
analysis of known bioactive substances. The planar yeast estrogen screen (pYES), by 
contrast, provides the possibility to chromatographically separate single substances of a 
sample in a planar system and to detect the estrogenic activity of single compounds 
afterwards. However, samples of interest, especially environmental samples, often contain 
various native fluorescing compounds (red, blue fluorescence) that can interfere with the 
detection of EAC when employing the generally used substrate 4-methylumbelliferyl-E-D-
galactopyranoside, which releases blue fluorescing 4-methylumbelliferone as positive signal 
of estrogenic activity. Since screenings are particularly meant to deliver fast results and thus 
should not need complex sample preparation or purification steps, the pYES represents a 
suitable method, simultaneously providing a planar clean-up. For this purpose, however, 
special advancements need to be reached to clearly differentiate pYES fluorescence signals 
due to estrogenic activity from the native fluorescence of sample compounds. 
By usage of the substrate resorufin-E-D-galactopyranoside (RGP), which releases orange 
fluorescing resorufin as positive signal of estrogenic activity, and by employing fully 
automated devices, the RGP-pYES was developed as fast screening tool for the detection, 
determination, and identification of EAC (chapter II, 1). Subsequently, the RGP-pYES was 
successfully applied on sewage and hops pellet samples (chapter II, 1 and 3). Moreover, the 
pYES enabled the determination of estradiol equivalent factors, estradiol equivalent 
concentrations, and estradiol equivalent amounts of known and unknown EAC in liquid and 
solid samples (chapter II, 2 and 3).
The developed RGP-pYES provided the combination of high-performance thin-layer 
chromatography (HPTLC) and the detection of EAC by means of genetically modified yeasts 
in a single test. During method development it became apparent that due to the pH value of 
the HPTLC plate (water-wettable reversed phase plates, RP-18 W, pH ~4.7) a pretreatment 
of the plate was necessary (chapter II, 1). By treating the plates with a solution of sodium 
hydrogen carbonate (pH 6.4) the pH of the plate was raised to about 6.5 in order to ensure 
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an optimal activity of the yeasts and of the enzyme released due to estrogenic 
activity (chapter II, 1). After liquid-liquid extraction (LLE) of water samples with tert-butyl 
methyl ether and enrichment, the extracts were applied as areas whereas the standard 
solutions were applied as bands onto the pretreated HPTLC plates, followed by pYES 
(chapter II, 1). After chromatography, the plates were dipped in a suspension of recombinant 
yeasts, containing the human estrogen receptor (hER) and additionally a reporter gen that 
encodes for the enzyme E-galactosidase. Present EAC are bound by the hER which leads to 
the expression of the reporter gene and thus to the production of the enzyme. The enzyme 
cleaves the substrate RGP, which releases orange fluorescing resorufin in the respective 
HPTLC zones. The developed pYES provided limits of detection of 3 ± 0.5 and
4 ± 0.7 pg/zone for 17E-estradiol and 17D-ethinylestradiol, respectively, (corresponding to 
0.4 ng/L and 0.6 ng/L in view of water samples after the employed LLE), and limits of 
quantitation of 5 ± 1.8 and 8 ± 1.0 pg/zone (n = 7), respectively (chapter II, 1). The watch list 
of the European Commission states maximum acceptable method detection limits of 0.4 ng/L 
for 17E-estradiol and 0.035 ng/L for 17D-ethinylestradiol. Thus, the developed pYES meets 
the requirement for 17E-estradiol, but not for 17D-ethinylestradiol. To reach the maximum 
acceptable detection limit for 17D-ethinylestradiol, however, solely higher sample volumes 
need to be extracted. The LLE in combination with the pYES provided mean recoveries for 
spiked water samples at four spiking levels in a range of 2–20 ng/L for both mentioned EAC 
between 91 and 113% (n = 6) with relative standard deviations (RSD) of 15–25% (chapter II,
1). Subsequently, the developed pYES was applied on influent and effluent samples of a
waste water treatment plant (plant for about 10,000 inhabitants). Employing pYES for the 
determination of EAC in these samples, one EAC (unknown) was detected in the effluent, 
while four EAC (17E-estradiol in a concentration of about 17 ng/L, estrone, estriol and 
another unknown) were detected in the influent (chapter II, 1). Moreover, conjugated EAC 
were detected in the influent sample (estrone and the unknown EAC), by an additional 
incubation of the samples with glucuronidase (with an additional sulfatase activity) before 
extraction and comparison of the pYES-signal intensities (chapter II, 1). By the use of RGP 
as substrate, positive signals of estrogenicity were observable in the form of orange
fluorescing zones under UV 254 nm illumination and as pink zones under white light, 
enabling a clear differentiation from zones of substances with native fluorescences. This 
impressively shows the enormous advantage of this substrate and the applicability of the 
RGP-pYES as screening tool for EAC in environmental samples.
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The performance of the pYES is based on receptor-transmitted reactions and thus 
represents a receptor test. At this, respective ligands are bound by the hER whereby the 
receptor is activated which leads to further reactions. Such processes are usually equilibrium 
processes that show a saturation behavior, which is observable in sigmoidal dose-response 
curves, when the obtained signals are plotted against the logarithmized concentrations or 
amounts, respectively. Saturation curves enable the evaluation of receptor tests by means of 
the logit-log method performing a transformation of the respective signals into logit-values, 
whereby linear calibration graphs are obtained as result. The assumption of a possible 
transfer of this method to pYES was verified and demonstrated (chapter II, 2). During 
examination of the pYES-signals it became apparent that no sigmoidal curves were obtained 
by using peak areas since an increasing amount of analyte led to wider HPTLC zones and 
thus to steadily increasing peak areas (chapter II, 2). By employing peak heights, in contrast, 
sigmoidal curves were obtained, which subsequently could be transformed to linear 
calibration graphs by means of the logit-log method (chapter II, 2). Using logit-log plots 
advantageously allowed the expansion of the working range to 5–500 pg/zone (linear graphs 
with good correlations over two decades) in comparison to an upper limit of 200 pg/zone 
when polynomial calibration graphs were used (chapter II, 1 and 2). The renewed evaluation 
of the data obtained for the spiked water samples employing logit-log plots (4 spiking levels 
in a range of 2 to 20 ng/L, chapter II, 1) resulted in mean recoveries for 17E-estradiol and 
17D-ethinylestradiol between 83 and 123% (n = 5) with RSD of 10–24% (chapter II, 2), and 
thus showed similarity to the former results (chapter II, 1). 
The generation of dose-response curves and thus logit-log plots additionally enabled the 
determination of half maximal effect doses (ED50) for 17E-estradiol and 17D-ethinylestradiol, 
easily determined from the intersection of the linear calibration graph with the abscissa 
(chapter II, 2). Thus, the estradiol equivalent factor of 17D-ethinylestradiol was determined 
to 0.64 (chapter II, 2). In addition, the theory was enunciated that by employing ED50-values 
or half maximal effect volumes (EV50) of samples or sample extracts, the EC50-method can 
be applied for the estimation of estradiol equivalent concentrations (EEQ) and thus the 
estrogenic potential of samples or sample extracts (chapter II, 2). This was demonstrated in 
the course of the further work (chapter II, 3). 
To demonstrate the applicability of the developed pYES on further samples, subsequently 
hops pellet samples were investigated. The presence of EAC in beer – and that hops is the 
source of these substances – is known for a long time. To show the advantages of the RGP-
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pYES, simple hops extracts were examined and compounds showing pYES-positive signals 
were identified by means of mass spectrometry (MS) afterwards. The extraction of the hops 
samples was simply executed with ethanol in an ultrasonic bath, and after RGP-pYES, a low 
amount of an EAC was detected in the extract (chapter II, 3). The prenylated flavanone 
8-prenylnaringenin (8-PN) is known to be the most potent estrogenic substance in hops.
Since during the brewing process of beer the inactive but isobaric prenylated chalcone 
desmethylxanthohumol is transformed into 8-PN and 6-prenylnaringenin (also a weak EAC of 
hops), the hops pellets additionally were treated under heat apply in water for an hour (‘wort 
boiling’) and the hops’ remainder was extracted afterwards (chapter II, 3). Simultaneously, 
the hops sample was also stirred in cold water for the same time. After pYES, an obviously 
higher amount of the EAC in the hops’ remainder extract after heat treatment was observable 
in comparison to a hops’ remainder extract without heat apply, demonstrating the heat-
induced formation of the detected EAC, later identified and confirmed as prenylnaringenin
(chapter II, 3). Additionally, the hops’ remainders of four different hop varieties (two varieties
from Germany, one variety from Great Britain and one from the United States of America) 
after the simulation of the wort boiling were investigated by pYES. In all four sample extracts 
only one EAC was detectable, however, the amount of the EAC differed in the distinct hop 
varieties (chapter II, 3). By comparison of the different applied extracts, the advantages of 
the RGP-pYES became obvious. On the one hand, the planar chromatographic method is 
perfectly suitable to see all extracted compounds of a sample, including differences in 
amounts of these compounds, directly on the plate. On the other hand, the application of the 
RGP-pYES enables a clear differentiation between zones of native fluorescing compounds of 
the extracts (blue, red) and zones showing estrogenic activity indicated by the orange 
fluorescence of resorufin (chapter II, 3). An HPTLC method also allows the identification of 
unknown substances by performing MS detection, as used for the EAC of the hops’
remainder extract that thus could be identified and confirmed as prenylnaringenin 
(chapter II, 3). 
Furthermore, using the example of the hop flavanone prenylnaringenin, the assumption of 
the possible determination of EEQ of sample extracts (chapter II, 2) was verified, and the 
term estradiol equivalent amount (EEA) for solid samples was introduced (chapter II, 3). For 
this purpose, different volumes of a hops’ remainder extract after heat treatment were 
applied onto an HPTLC plate and the obtained peak heights of the pYES-signals were 
plotted against the logarithmized application volumes resulting in sigmoidal curves 
(chapter II, 3). After generating the respective logit-log plot, the EV50-value was determined 
from the intersection of the linear graph with the abscissa. Thus, the EEQ of the hops’
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remainder extract after heat treatment was determined to 39 µg/L and the EEA of the hops’ 
remainder after heat treatment to 52 µg/kg, corresponding to an estrogenic activity of 52 µg 
17E-estradiol per kg hops (chapter II, 3). 
In conclusion, the RGP-pYES represents a fast screening method, which provides the 
separation of sample components after a simple extraction, including the detection and 
determination of EAC, while all compounds of the extracts are visible on the plate at one 
look. At this, the clear differentiation of native fluorescences of sample components and 
fluorescences of positive signals for estrogenic activity is given (chapter II, 1 and 3). The 
separation of the analytes allows the determination of individual substances, thus, not 
leading to a sum parameter as result. Moreover, the orange fluorescing zones after pYES 
indicate the substances which are showing an activity at the human estrogen receptor. The
RGP-pYES was successfully applied to water samples and thus demonstrated its suitability 
as monitoring tool for waters and sewage (chapter II, 1). With regard to the watch list of the 
European Commission, the screening also shows the connection to currently relevant issues. 
Additionally, also the applicability for other samples such as hops pellets as well as the 
coupling to MS for the identification of unknowns was demonstrated (chapter II, 3). By 
generation of dose-response curves, moreover, the possibility for an alternative evaluation by 
means of logit-log plots, the determination of estradiol equivalent factors as well as the 
estimation of the estrogenic potential of samples or single sample components in terms of 
estradiol equivalent concentrations and estradiol equivalent amounts was pointed out
(chapter II, 2 and 3).
The pYES ought to be qualified to investigate further matrices, which has to be verified in 
future experiments. In addition, by an appropriate selection of analytes and chromatographic 
conditions, the possibility to execute a targeted analysis of specific substances of interest is 
given. As example, the analysis of nonylphenols is to be mentioned. The placing on the 
market, the manufacture and the usages of nonylphenols and nonylphenol ethoxylates is 
regulated by the European Union as group, why their determination is of great interest. A 
targeted analysis could take place, for example, by focusing nonylphenol derivatives in a 
target zone separated from other sample components on the plate, followed by the
determination of the total nonylphenols – corresponding to existing regulations – by pYES. 
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IV Summary
Substances that disrupt or impair the hormone system (endocrine system) or that show an 
irreversible influence on it are referred to as endocrine disruptors or xenohormones. 
Concerning this, also estrogen active compounds (EAC) are endocrine disruptors, that are 
under suspicion of being involved in the formation of tumors or to induce disruption during 
development and reproduction, and are, for example, blamed for being responsible for the 
feminization of fish. At this, EAC can be natural (human, phytoestrogens) but also synthetic 
substances, which are discharged to the environment by humans (e.g. pharmaceuticals, 
pesticides, additives). Regarding the ubiquitous presence of EAC and with respect to the 
watch list of substances of the European Commission for Union-wide monitoring in the field 
of water policy of the year 2015 (includes four EAC, inter alia ethinylestradiol EE2, estradiol 
E2 with a maximum acceptable method detection limit of 0.4 ng/L), suitable methods for the 
analysis of EAC are required. For that purpose, several in vivo and in vitro methods are 
available by which, however, often only the effect on the organism and the whole bioactivity 
of a sample, respectively, are considered, and in their course no determination or 
identification of single EAC takes place. The YES assay (yeast estrogen screen), for 
example, is a cell-based method that is executed in liquid solutions in microtiter plates and 
works with genetically modified yeasts, which contain the human estrogen receptor (hER) 
and a reporter gene encoding for the enzyme E-galactosidase. In presence of EAC, the 
enzyme is produced and subsequently cleaves a substrate that is used to measure the 
receptor activity and thus the estrogenic activity. The transfer of the YES assay to high-
performance thin-layer chromatography (HPTLC) was successfully demonstrated and 
advanced, thus resulting in the combination of a chromatographic separation of analytes and 
the detection of EAC using genetically modified yeast cells directly on the HPTLC plate 
(HPTLC planar yeast estrogen screen, HPTLC-pYES). Usually, the substrate 4-
methylumbelliferyl-E-D-galactopyranoside is used, releasing blue fluorescing 4-
methylumbelliferone (MU) after enzymatic cleavage as positive signal for estrogenic activity. 
Samples of interest to be investigated, however, often contain plenty of components, partly 
showing native fluorescences (blue, red), why the detection of the blue fluorescing MU can 
be interfered. 
The objective of the presented research work was to introduce a suitable substrate, which 
allows the detection of EAC without interferences by a clear differentiation between positive 
signals due to estrogenicity and signals due to native fluorescences. Applying this substrate, 
a pYES should be developed, allowing a fast screening for EAC in water and sewage 
samples, while single components are separated from each other by HPTLC and a possible 
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estrogenic activity of the single substances can be detected directly on the HPTLC plate. The 
single EAC should be identified with suitable standard substances or by coupling to mass 
spectrometry (MS). 
By applying the substrate resorufin-E-D-galactopyranoside (RGP) and by using automated 
devices, the RGP-pYES as fast screening tool for EAC was developed in the course of this 
research work and was successfully applied to waste water samples and extracts of hops 
pellet samples. A screening method using HPTLC simultaneously represents a planar clean-
up, why samples do not have to undergo complex steps of sample preparation or purification.
A chromatographic separation in combination with the detection of estrogenic activity using 
genetically modified yeasts directly on the plate allowed the detection, the determination and 
the identification of single EAC. Using RGP, which releases orange fluorescing resorufin 
after enzymatic cleavage, enabled to clearly differentiate between fluorescences due to
estrogenicity and the native fluorescence of sample components. Application of the RGP-
pYES to spiked water samples and sewage samples showed high recovery rates (close to 
100% for both E2 and EE2 with relative standard deviations 25%) and a good precision (E2 
in the waste water influent with a concentration of ~17 ng/L, relative standard deviation of 
11%, n = 4), and thus the applicability of the screening as monitoring tool for environmental 
samples and the connection to current issues (watch list; detection limit for E2 was 
determined to 0.4 ng/L).
By means of the developed pYES and suitable evaluation methods, additionally the option to 
generate dose-response curves of known and unknown EAC was given and the generation 
of so-called logit-log plots was possible. This enabled the determination of estradiol 
equivalent factors of known EAC and also the determination of estradiol equivalent 
concentrations and amounts, respectively, of known and unknown EAC in liquid and solid 
samples. Thus, the possibility to estimate the estrogenic potential of a sample or single 
sample components was given. The coupling of pYES to MS additionally allowed the 
identification of unknown EAC, demonstrated exemplarily by investigation of extracts of hops 
pellet samples, in which the only detected EAC in the hops extracts was identified as 
prenylnaringenin. 
Since the pYES is a method that uses a planar system, it provides the advantage to see all 
chromatographically separated sample components at one look. Additionally, pYES provides
the evidence of a possible estrogenic activity (activity at the hER) of single substances, when 
a differentiation between native occurring fluorescences of sample contaminants and the 
fluorescence as positive signal for estrogenicity of a substance is granted. 
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V Zusammenfassung
Stoffe, welche das Hormonsystem (endokrine System) irreversibel beeinflussen, stören oder 
beeinträchtigen, werden als endokrine Disruptoren oder auch als Xenohormone bezeichnet. 
Hierzu zählen auch östrogen wirksame Stoffe (estrogen active compounds, EAC), welche 
unter anderem im Verdacht stehen bei der Tumorbildung beteiligt zu sein oder Störungen in 
der Entwicklung und Reproduktion hervorzurufen, und beispielsweise für die Verweiblichung 
von Fischen verantwortlich zu sein. EAC können hierbei natürlichen Ursprungs (menschlich, 
pflanzlich) sein oder synthetisch hergestellte Stoffe, welche durch den Menschen in die 
Umwelt eingetragen werden (z.B. Arzneimittel, Pestizide, Additive). Aufgrund des ubiquitären 
Vorkommens von EAC und der 2015 von der Europäischen Kommission veröffentlichten 
Beobachtungsliste (watch list) für die unionsweite Überwachung im Rahmen der 
Wasserpolitik (beinhaltet vier EAC, u.a. Ethinylestradiol EE2, Estradiol E2 mit einer 
höchstzulässigen Nachweisgrenze NG von 0,4 ng/L) sind geeignete Methoden zur 
Untersuchung auf EAC erforderlich. Hierfür stehen einige in vivo und in vitro Verfahren zur 
Verfügung, wobei jedoch häufig nur die Wirkung auf den Organismus bzw. die gesamte 
Bioaktivität der Probe betrachtet wird und keine Bestimmung oder Identifizierung der 
einzelnen EAC erfolgt. Ein Beispiel einer zellbasierten Methode ist der YES-Assay (yeast 
estrogen screen), welcher in flüssigen Medien in Mikrotiterplatten durchgeführt wird und mit 
genetisch modifizierten Hefen arbeitet, die den humanen Östrogenrezeptor (human estrogen 
receptor, hER) und ein Reportergen enthalten, welches für das Enzym E-Galactosidase 
kodiert. In Anwesenheit von EAC wird das Enzym produziert und setzt anschließend ein 
Substrat um, welches zur Messung der Rezeptor- und damit der Östrogenaktivität dient. Die 
Übertragung des YES-Assay auf die Hochleistungs-Dünnschichtchromatographie (high-
performance thin-layer chromatography, HPTLC) wurde erfolgreich gezeigt und 
weiterentwickelt, so dass eine chromatographische Trennung der Analyten mit dem 
Nachweis der EAC unter Verwendung genmodifizierter Hefezellen direkt auf der HPTLC-
Platte kombiniert werden konnte (HPTLC planar yeast estrogen screen, HPTLC-pYES). 
Hierbei findet für gewöhnlich das Substrat 4-Methylumbelliferyl-E-D-Galactopyranosid seinen 
Einsatz, welches nach enzymatischer Spaltung blau fluoreszierendes 4-Methylumbelliferon 
(MU) als positiven Nachweis östrogener Aktivität freisetzt. Häufig beinhalten die zu 
untersuchenden Proben jedoch viele Begleitkomponenten, welche zum Teil native 
Fluoreszenzen aufzeigen (blau, rot), wodurch der Nachweis des blau fluoreszierenden MU 
gestört werden kann.
Ziel dieser Forschungsarbeit war es, ein geeignetes Substrat zu finden, welches die 
störungsfreie Detektion von EAC ermöglicht, indem Positivsignale deutlich von nativen 
Fluoreszenzen unterschieden werden können. Mittels dieses geeigneten Substrates sollte 
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ein pYES entwickelt werden, welcher ein schnelles Screening auf EAC in Wasser- bzw. 
Abwasserproben ermöglicht, wobei Einzelkomponenten mittels HPTLC getrennt werden und 
eine mögliche östrogene Wirksamkeit einzelner Substanzen direkt auf der HPTLC-Platte 
nachgewiesen wird. Einzelne EAC sollten hierbei durch geeignete Standardsubstanzen oder 
durch Kopplung mit Massenspektrometrie (MS) identifiziert werden können.
Durch die Wahl des Substrates Resorufin-E-D-Galactopyranosid (RGP) und unter 
Verwendung automatisierter Geräte konnte im Verlauf dieser Forschungsarbeit der RGP-
pYES als schnelles Screening auf EAC entwickelt und erfolgreich auf Abwasserproben und 
Extrakte von Hopfenpellets angewandt werden. Ein Screening unter Einsatz der HPTLC stellt 
gleichzeitig ein planares Clean-up dar, wodurch die Proben keinen aufwändigen Reinigungs-
oder Aufarbeitungsschritten unterzogen werden müssen. Die chromatographische Trennung 
in Kombination mit dem Nachweis östrogener Aktivität mittels genmodifizierter Hefen direkt 
auf den Platten ermöglichte den Nachweis, die Bestimmung und die Identifizierung einzelner 
EAC. Die Verwendung des RGP, welches durch enzymatische Spaltung orange 
fluoreszierendes Resorufin freisetzt, erlaubte hierbei eine klare Differenzierung von 
Fluoreszenzen aufgrund östrogener Wirksamkeit gegenüber nativer Fluoreszenz von 
Probenkomponenten. Die Anwendung des RGP-pYES auf Extrakte von gespikten 
Wasserproben und Abwasserproben zeigte hohe Wiederfindungsraten (~100% für E2 und 
EE2, relative Standardabweichungen RSD 25%) und eine gute Präzision (E2 ~17 ng/L im 
Abwasserzufluss, RSD 11%, n = 4) und damit die Eignung des Tests als Monitoring-Tool für 
Umweltproben, und den Bezug zu aktuellen Fragestellungen (watch list; NG für E2 zu 
0,4 ng/L bestimmt). Mittels des entwickelten pYES und geeigneter Auswerteverfahren war es 
zudem möglich, Dosis-Wirkungs-Kurven bekannter und unbekannter EAC und damit 
sogenannte logit-log Plots zu erstellen. Dies ermöglichte die Bestimmung von Estradiol-
Äquivalenz-Faktoren bekannter EAC sowie die Ermittlung von Estradiol-Äquivalenz-
Konzentrationen bzw. -Gehalten bekannter und unbekannter EAC in flüssigen und festen 
Proben, womit die Möglichkeit der Abschätzung des östrogenen Potentials einer Probe oder 
einer einzelnen Probenkomponente gegeben ist. Die Kopplung des pYES mit der MS 
erlaubte zusätzlich die Identifizierung unbekannter EAC, wie am Beispiel der Untersuchung 
von Extrakten von Hopfenpellets gezeigt werden konnte, in welchen Prenylnaringenin als 
einzig nachweisbare EAC der Hopfenextrakte identifiziert wurde. Als Methode im planaren 
System bietet der pYES den Vorteil, alle chromatographisch getrennten Probenbestandteile 
auf einen Blick zu sehen, und zusätzlich durch den Biotest eine mögliche östrogene Aktivität 
(Aktivität am hER) der Einzelsubstanzen anzuzeigen. Hierbei kann zwischen nativ 
auftretenden Fluoreszenzen der Probenkomponenten und der Fluoreszenz als Positivsignal 
der östrogenen Wirksamkeit einer Substanz differenziert werden.
